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Regulation of cell cycle is crucial for cell survival and function. Dysregulated cell 
division can result in multiple disorders, including cancer, neurological, renal and 
vascular proliferative diseases. Changes in cellular lipidome during the cell cycle 
has become an increasingly important research area. Here, we investigated the 
lipid composition of cells in different stages of the cell cycle using mass 
spectrometry-based lipidomics approaches. We used two complementary 
synchronisation methods (G1/S by aphidicolin and G2/M by nocodazole) with 
two different cell lines (HeLa- human cervical cancer cell line and MCF7- human 
breast cancer cell line). Among the lipid classes analysed, which included 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol 
(PI), phosphatidylglycerol (PG), sphingomyelin (SM), ceramide (Cer), 
glucosylceramide (GluCer), triacylglycerol (TAG), diacylglycerol (DAG) and 
sterols, cholesterol esters showed a significant increase in G2/M phase. This 
highlights that cholesterol esters may be a fundamental lipid class for cell division, 
as they could act as a store for cholesterol and fatty acids, which are essential 
components of phospholipids and are critical for membrane biogenesis in cell 
division.  
Acyl-coA:cholesterol acyltransferase 1 (ACAT1) is the main intracellular enzyme 
involved in cholesterol esterification. We confirmed the importance of cholesterol 
esters in cell cycle using ACAT1 knocked-down (KD) cells which have lower 
levels of cholesterol esters. Cell cycle kinetics of ACAT1 KD and negative 
control cells were compared. A prolonged G2/M phase in ACAT1 KD cells was 
 vi 
 
observed, indicating that cholesterol esters metabolism is crucial especially for 
G2/M progression. 
One of the consequences of cell cycle dysregulation is the development of cancer. 
The connection between cell cycle and cancer is critical. The cell cycle machinery 
controls cell proliferation and cancer is a condition of uncontrolled cell division. 
Lipids have been reported to play a role in cancer. Hence, using breast cancer as a 
model, we conducted a pilot study to profile and compare lipids in human breast 
tumor and control tissues. Among other findings, we observed an increase in 
cholesterol esters in the tumor samples when compared to control. This further 
supports our previous results, where cholesterol esters were found to be important 
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Lipids are a group of biomolecules that are generally insoluble in water but 
soluble in organic solvents, but with exceptions. In mammalian cells, lipids are 
the second largest component in cellular mass after water. They are generally 
categorised based on their common chemical properties, such as their headgroups, 
or polarity (Cui and Thomas, 2009). Some of the main categories of lipids are 
illustrated in Figure 1.1, particularly neutral lipids (triacylglycerol, diacylglycerol 
and sterols) and polar lipids (phospholipids and sphingolipids). Within each group, 
there are species with different fatty acyl chain lengths or varying degrees of 
unsaturation. Many studies on fatty acid composition indicate that the number of 
different fatty acid species found in lipids in a typical mammalian tissue ranges 
from 30 to 60. Based on random permutations and combinations of various 
positions of the fatty acyl backbone at sn-1 (stereospecific numbering) or sn-2 and 
functional headgroups in mammalian lipids, there would be more than 1000 





Figure 1.1 Categories of lipids with examples. (A) Fatty acyl chains which are 
the components of lipids' hydrophobic fatty acid chains. (B) Neutral lipids which 
consist of (i) glycerolipids, (ii) sterols and (iii) waxes. (C) Polar lipids which 
consist of (i) glycerophospholipids (phospholipids for short) with two fatty acyl 
chains and a phosphate headgroup which defines the lipid class; (ii) sphingolipids 
which consist mainly of ceramides and sphingomyelin. Chemical structures are 
obtained from LipidMaps. 
A. Fatty acyls




























Phospholipids are well known for their amphiphilic nature. They are involved in a 
diverse array of functions such as signal transduction and execution of both 
cellular proliferation and death programs, and are major structural components of 
cellular membranes. The plasma membrane defines the outer most boundary for 
the chemistry of life, while the inner membrane systems or organelles provide an 
organisational framework to compartmentalise chemical reactions, ie. cellular 
metabolism. Alterations in membrane lipid composition have an impact on a 
broad range of cellular functions, like membrane permeability, transport systems, 
activity of membrane-bound enzymes, cell growth, proliferation and viability 
(Spector and Yorek, 1985). It is the combination of these activities, membrane 
biogenesis and energy metabolism, that enable cells to grow and multiply. Hence, 
it is logical to assume that cells need to coordinate membrane biogenesis with 
basic metabolism to ensure successful replication with transfer of their genes 
(Loewen, 2012).  
1.1.2 Mass spectrometry 
 
The end of the 20
th
 century was marked by the genomics revolution, where the 
human genome was finally unraveled. Proteomics was the hottest topic in the 
beginning of the 21
st
 century, with a lot of efforts trying to link genomics and 
proteomics, thereby creating the field of transcriptomics. Genomic and proteomic 
advances have shown the necessity to explore metabolic processes at the system 
level (Ivanova et al., 2009). However, genes and transcripts do not always predict 
the levels of active proteins or enzymes (Dennis, 2009), and hence, are not good 
indicators of metabolite levels. It has also been understood that metabolite 
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concentrations represent sensitive markers of both genetic and phenotypic 
changes (Cuperlovic-Culf et al., 2010). Hence, metabolomics came into the 
picture, with lipidomics being a part of it. 
Lipidomics is the systematic identification and analysis of the lipid molecular 
species of a cell, living tissue or whole organism with emphasis on quantitating 
compositional changes in response to perturbations, like cancer growth or drug-
induced alteration in metabolism (Brown, 2012). It is deemed as a logical 
outcome of the history and traditions of lipid biochemistry, where mass 
spectrometry technical advances play critical roles in providing a deeper 
understanding of the cellular functions of lipids (Ivanova et al., 2009).  
Mass spectrometry, with high sensitivity, specificity, selectivity and speed, is an 
ideal tool to analyse lipids (Milne et al., 2006). The development of “soft” 
ionization methods like matrix-assisted laser desorption/ionization (MALDI) and 
electrospray ionization (ESI), and tandem mass spectrometry (MS-MS) made 
lipid detection and measurement more accurate and comprehensive (Milne et al., 
2006; Wenk, 2005). Measurements of individual lipid species in a complex lipid 
mixture is now possible, with minimal sample processing needed. Lipid analytes 
and the matrix have good solubility in organic solvents, resulting in excellent 
signal-to-noise ratios and reproducibility (Wenk, 2005). MALDI-TOF (time-of-
flight) has been successfully used to image the phospholipid distribution in tissues 
(Malmberg et al., 2007; Puolitaival et al., 2008; Richter et al., 2007). However, 
ESI is now more commonly chosen to profile complex lipid mixtures, as it offers 
high sensitivity and specificity for a wide range of lipids (Wenk, 2005), including 
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phospholipids (Brügger et al., 1997), sphingolipids (Sullards and Merrill, 2001) 
and even non-polar lipids like triacylglycerides, diacylglycerides (Han and Gross, 
2001) and sterols. ESI involves the production of lipid ions by evaporating off 
solvents in which the lipids are dissolved. The lipid ions can be generated by 
adding a proton [M+H]
+
, by adducting a cation like Na
+
 to form [M+Na]
+
, or by 
removing proton to form [M-H]
-
. These ions are then channelled to mass 
analysers such as a quadrupole or TOF. There, the lipid ions are selectively 
filtered based on their mass-to-charge ratio (m/z), and will exit the analyser at 
given voltages to reach the detector (Cui and Thomas, 2009). 
Analysis of known substances can be done with limited range scanning and 
selected ion monitoring. Tandem (MS-MS) method provides higher sensitivity for 
comprehensive lipid analysis. It involves multiple steps of ion selection with 
fragmentation between stages. The most commonly used triple quadrupole (QqQ) 
consists of two mass analysers, Q1 and Q3, separated by a collision-induced 
dissociation (CID) chamber (Cui and Thomas, 2009). Figure 1.2 shows a 
schematic diagram of the process. Multiple reaction monitoring (MRM), which 
monitors both Q1 and Q3 mass characteristic of each molecule, is often used for 
quantification of already-known molecules. Product or daughter ions arising from 
both positive and negative ion mode fragmentation processes yield a lot of 
information on fatty acid, lysolipid and head-group related fragments which are 
specific for each lipid type (Ivanova et al., 2009). This method offers a more 
sensitive and accurate measurement of specified molecules than other MS 
methods like the precursor ion (Q1) scan (Nakanishi et al., 2009). For instance, 
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PC 34:0 (phosphatidylcholine with 34 carbon atoms in its two saturated fatty acyl 
chains) and PS 34:1 (phosphatidylserine with a total of 34 carbon atoms in its two 
fatty acyl chains with 1 unsaturated bond) are isobaric in positive mode and not 
distinguished by MS1 (Q1) alone. MS-MS is therefore needed to separate the two 
species, based on their characteristic daughter ions in MS2 (Q3). In addition, 
MRM can be quantitative when used with relevant internal standards (Wenk, 
2005). 
 
Figure 1.2 Schematic diagram of MRM in a triple quadrupole. The parent ion 
with the intended m/z is selected in Q1 and sent for fragmentation in q2 where 
collision-induced dissociation (CID) takes place. The parent ion is fragmented 
into many smaller ions. The daughter or fragmented ion with a specific m/z 
characteristic of the desired molecule is then allowed to enter Q3 and reach the 
detector. 
 
Apart from the presence of isobaric species, some of the limitations in MS 
analysis include ion suppression and exact lipid identification. These would 
require additional steps to resolve. For instance, separation of the complex lipid 
mixture is enhanced by the addition of chromatography prior to the analyte's entry 
into the mass spectrometer. This results in less ion suppression, high ionisation 
yield and better sensitivity for minor species (Ivanova et al., 2009). Apart from 










performance liquid chromatography (HPLC) including normal phase and reverse 
phase chromatography has introduced more possibilities into the science of 
separating lipids based on their chemical properties more efficiently and 
selectively. The former separates lipids based on their headgroups, while the latter 
separates lipids by the fatty acid composition (Pulfer and Murphy, 2003). More 
recently, chromatographic columns have evolved to be more efficient by having 
new column chemistries and reduced particle size (Wenk, 2005). 
1.2 Cell cycle and lipids 
The eukaryotic cell division cycle is one of the most rigorously studied biological 
processes. It is divided into the sequential G1 (Gap 1), S (Synthesis) and G2 (Gap 
2), collectively known as interphase, and M (mitotic) phases. In appropriate cues, 
cells may exit from the cell cycle and enter quiescent state (G0) or proceed into 
the next cycle. The two main events in the cell cycle are DNA synthesis in S 
phase, and the division of the parent cell into two daughter cells in the M phase. 
G1 and G2 are periods in the cell cycle where the cell prepares to replicate its 
genomic material and then to divide respectively. The transition from one phase 
of the cell cycle to another occurs in a unidirectional fashion and is traditionally 
known to be regulated mainly by cyclins and cyclin-dependent kinases (Cdk) in a 
spatial and temporal manner (Bollen et al., 2009; Malumbres, 2011). Different 
phases of the cell cycle are controlled mainly by a unique pair of Cdk-cyclin. 
While Cdk protein levels remain consistent throughout the cell cycle, protein 
levels of their activating partners cyclins fluctuate during the cell cycle. This 
 8 
 
results in the periodic activation of Cdk, which leads to the progression of cell 
cycle (Figure 1.3) (Vermeulen et al., 2003). 
 
Figure 1.3 The stages of the cell cycle. The respective Cdk/cyclin complexes 
that are essential for cell cycle progression are indicated (Vermeulen et al., 2003). 
 
Building of a new cell is an extraordinarily energy-consuming task. It is 
dependent on various metabolic and biosynthetic processes, most of which are 
crucial for biomass accumulation (Cai and Tu, 2012). In order to progress through 
the cell cycle smoothly and eventually divide into two, the cell should ideally 
duplicate its contents, which would then be distributed to the daughter cells. Two 
main biosynthetic activities required by proliferating cells are ribose-5-phosphate 






























linked to glucose and glutamine metabolism (DeBerardinis et al., 2008). More and 
more links have been made between cell metabolism and cell cycle control 
(DeBerardinis et al., 2008; Vander Heiden et al., 2009). For instance, cyclins have 
been linked to cell metabolism. Gene expression from cyclin D1- knockout mice 
showed cyclin D1's inhibitory effects on numerous target genes in glycolysis, 
lipogenesis and mitochondrial activity. Cyclin D1 knockdown in breast cancer 
cells caused an increase in pyruvate kinase levels, thereby promoting glycolysis. 
Levels of fatty acid synthase (FAS) and acetyl-coA carboxylase (ACC), which are 
essential for fatty acid biosynthesis, were also increased (Sakamaki et al., 2006). 
How metabolic changes affect the cell cycle and vice versa has become an 
increasingly important question, with lipids being one of the major metabolites. 
Cell cycle plays essential roles in various critical biological events, ranging from 
multicellular development, wound healing and regeneration to gametogenesis 
(Cho et al., 2001). Functional genomics studies have been carried out on various 
biological models like bacteria (Laub et al., 2000), yeasts (Cho et al., 1998; 
Spellman et al., 1998), primary cells (Bar-Joseph et al., 2008; Cho et al., 2001) 
and cancer cell lines (Whitfield et al., 2002).  These studies shed light into almost 
all possible aspects of cell cycle control, including DNA replication in S phase, 
sister chromatids segregation in mitosis, extracellular matrix remodelling in 
cytokinesis. Efforts to plough through these vast amount of genomics data for 
lipid related genes in human cell cycle have been unfulfilling, with only a subset 
of genes of lipid related proteins being found to be regulated cyclically along with 




Figure 1.4 Summary of genes of lipid related proteins that are found to be 
regulated in the cell cycle in two published cell cycle genomics study. 
 
Since lipids are the major constituent of cellular membranes, one would expect 
cells to double their phospholipid mass during cell cycle in order for membranes 
to be distributed evenly between the two daughter cells. Several groups have 
attempted to understand how membrane phospholipid metabolism is regulated 
within the cell cycle. Findings are so far contradictory, and seem to be cell type 
specific. PCs are the main component of cellular membrane phospholipids 
(Jackowski, 1996). Jackowski (1994) observed periodic membrane PC 
degradation and synthesis during the cell cycle in a human macrophage cell line. 
G1 cells rapidly synthesise and degrade PC, while maintaining a constant total 
membrane phospholipid mass. PC degradation ceases in S phase to allow cells to 
double their membrane phospholipid content for cell division. The activity of the 
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rate-limiting PC synthesis enzyme CTP:phosphocholine cytidylyltransferase is the 
lowest in G2/M and it correlates with the cessation of phospholipid synthesis in 
G2/M (Jackowski, 1994). However, it was later reported that radiolabeled 
phospholipid precursors were rapidly incorporated during G2/M in breast cancer 
cell line MCF7 and Chinese Hamster Ovary (CHO) cells, suggesting that lipid 
synthesis occurs at G2/M as well. Key PC and PE biosynthetic enzymes, 
including CTP:phosphocholine cytidylyltransferase, were also found to be highly 
active at G2/M (Lin and Arthur, 2007). 
A scanning electron microscopy (SEM) examination of the cell surface changes in 
HeLa cells in different cell cycle stages reveals that the cell surface morphologies 
are characteristic in each cell cycle phase (Lundgren and Roos, 1976). For 
instance, mitotic cells were spherical and covered with microvilli structures of 
varying length. As the cells entered G1, they appeared to be flatter, with shorter 
microvilli and more blebs. All these morphological changes may be closely 
associated with changes in the lipid profiles of the membranes at different stages 
of the cell cycle. This is because each phospholipid has a different molecular 
shape and they each form a different polymorphic phase depending on the overall 
geometry when put together (Dowhan et al., 2008). For example, PC, 
sphingomyelin (SM), PS, PI, phosphatidylglycerol (PG) are cylindrical in shape, 
hence, they have the tendency to form bilayer phases. Phosphatidylethanolamine 
(PE), on the other hand, is cone shaped. In the presence of PE, membranes tend to 
form hexagonal phases. Lysophospholipids are inverted cone shaped, therefore 
they form micelles readily. 
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Relative abundance of cellular lipids is also critical to maintain. For example, the 
relative concentration of LPA and PA in biological membranes is a determining 
factor in membrane curvature and vesicle budding (Huijbregts et al., 2000), events 
that are crucial in the cell cycle. In addition, reduction in sterol to phospholipid 
ratio led to G1 arrest in proliferating cells (Cornell and Horwitz, 1980). In rat 
thymocytes, it was found that the cholesterol to phospholipid ratio increased 
during cellular growth (Gross et al., 1988). Since the phospholipid to cholesterol 
ratio is critical in determining membrane viscosity, it was hypothesized that the 
cell membranes develop towards a more ordered or condensed stage during cell 
growth. On the other hand, Cheng and Levy had reported that the lower 
cholesterol to phospholipid ratio resulted in a more fluidic lipid matrix, which, in 
turn, was correlated to cell proliferation (Cheng and Levy, 1979). 
Apart from maintaining cholesterol: phospholipid ratio, cholesterol has been 
reported to be essential for DNA, RNA and protein synthesis (Cornell and 
Horwitz, 1980). It is also important for proper mitosis completion and to prevent 
polyploidy cell formation. In the absence of cholesterol, cells could not undergo 
cytokinesis, thereby entering G1 with tetraploidy, then progressing through S 
phase into G2/M and resulting in polyploidy cells (Fernándeza et al., 2004). 
Besides their relative concentrations in the cell, cellular localization of 
phospholipids may also play essential roles in the regulation of cell cycle. For 
instance, levels of total cellular inositol lipids including phosphatidylinositol (PI), 
phosphoinositide phosphate (PIP), and PI(4,5)P2 relative to the total cellular 
phospholipids did not vary throughout the cell cycle. However, lipid profile of 
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isolated nuclei from synchronised cells revealed that levels of nuclear inositol 
lipids decreased by more than half as the cells entered S phase and returned to 
their original level after S phase. Levels of the cytoplasmic inositol lipids 
however remained constant throughout. This indicates that inositol lipid turnover 
is specific in the nucleus and is probably associated with DNA synthesis (York 
and Majerus, 1994). 
Another example illustrating the importance of lipid localisation in cell cycle 
would be the redistribution of phospholipids during cytokinesis. Cytokinesis, a 
final event in cell cycle, involves the membrane separation of the mother cell into 
two daughter cells. Apart from proteins for vesicle targeting and subsequent 
membrane merging, efficient membrane fusion events also require the recruitment 
of specific lipids to the cleavage furrow site for the completion of cytokinesis 
(Emoto et al., 2005). Emoto et al (1996) observed the exposure of PE on the cell 
surface especially at the cleavage furrow during the late telophase or cytokinesis. 
Immobilisation of PE on the cell surface prevented cytokinesis completion, 
indicating that plasma membrane phospholipids redistribution is critical for 
cytokinesis and that cell surface PE may be pivotal in maintaining coordinate 
movement between the contractile ring and plasma membrane to achieve 
successful cell division (Emoto et al., 1996). The same group of authors also 
showed that PI(4,5)P2 is predominantly localized at the furrow membrane during 
cytokinesis. This production on the inside of the furrow membrane was 
hypothesized to be coupled to the PE exposure on furrow surface (Emoto et al., 
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2005). Their findings collectively suggested that during cytokinesis, there is a 
unique membrane domain with a particular composition at the cleavage furrow. 
In addition to functioning as basic structural components of membranes, 
phospholipids also serve as substrates in many key regulatory signaling processes 
in the cells. For example, lipid phosphates, lysophosphatidate (LPA) and 
sphingosine-1-phosphate (S1P) act as signaling molecules intracellularly. PA can 
increase proliferation of cells through the mammalian target of rapamycin (mTOR) 
(Fang et al., 2001) and PA stimulates stress fiber formation (Ha and Exton, 1993). 
PC is also reported to be mitogenic by acting as a mediator of growth factor-
induced cell proliferation (Podo et al., 2011). The PC cycle is linked to many cell 
receptor-activated signal transduction pathways involving synthesis and 
utilization of other lipids and phospholipids (Vance and Vance, 2004). Choline 
deprivation blocks the synthesis of choline-containing lipids, which in turn causes 
the inhibition of lipid synthesis, and consequently G1 arrest (Cornell and Horwitz, 
1980). In fact, the elevated levels of phosphocholine and total choline detected in 
tumor cells can be interpreted as fingerprints of tumor progression (Podo et al., 
2011), an example of uncontrolled cell division. 
Catabolism of PC by phospholipase C (PC-PLC) generates second messengers 
and mitogens like diacylglycerol (DAG) and phosphocholine, thereby maintaining 
long-term cellular responses such as activation, proliferation, and differentiation 
events (Chen et al., 2010). DAG has been reported to be involved in the 
regulation of several intracellular pathways including the activation of protein 
kinase C isoforms (Diaz-laviada et al., 1990; Li et al., 2006), activation of NF-kB 
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(Schütze et al., 1992) and MAPK (Cecchetti et al., 2007). It has also been 
reported to interact with an essential cell cycle regulator, cell division cycle 20 
homolog (Cdc20), which is required for mitosis completion (Fu et al., 2009). 
Inhibition of PC-PLC could cause a G1 cell cycle arrest, related to Cdc20 (Chen 
et al., 2010).  
Other lipid-related enzymes have also been reported to be associated with cell 
cycle. For example, phospholipase D (PLD) plays a role in cell proliferation and 
cancer. It is activated in response to stimulators of vesicle transport, endocytosis, 
exocytosis, cell migration and mitosis (Schiffmann et al., 2009). Abnormalities in 
PLD expression and activity are associated with many human cancers. PLD 
serves as a survival signal that overcomes cell cycle arrest and apoptosis. It also 
acts as a progression factor to allow passage through cell cycle checkpoints, and is 
speculated to be needed for the competence of cells to pass the restriction point 
and exit from G0. 
Besides phospholipases, other lipid-associated enzymes are also implicated in 
cell-cycle related diseases. For example, lysophosphatidylcholine acyltransferase 
1 (LPCAT1), which converts lysoPC to PC, is found to be overexpressed in 
human colorectal cancer. It was suggested that upregulation of LPCAT1 can 
cause increased recycling of PC via the reacylation pathway, thus contributing to 
an enhanced membrane synthesis and altered membrane composition necessary 
for rapid tumor development and proliferation (Mansilla et al., 2009). 
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Phosphoinositide 3-kinase (PI3K) is reported to control early and late events in 
the mammalian cell cycle. It is needed for many events involved in cell division, 
like cyclin/Cdk regulation, translation initiation etc. It cooperates with other 
signaling pathways to control many cellular events (Garcia et al., 2006). 
Inhibition of PI3K has been observed to delay cell cycle progression of cells into 
G2/M phase (Shtivelman et al., 2002). Inactivated in quiescent cells, the first 
activity peak of PI3K occurs in G0/G1 transition, followed by mid-G1 to control 
Cdk2 by stabilizing cyclin E which is required for S phase. PI3K activity returns 
to basal during G2 until M phase entry when an additional minor PI3K activity 
peak is necessary (Garcia et al., 2006). 
Sterol regulatory element binding proteins 1 and 2 (SREBP-1 and SREBP-2), key 
regulators of genes involved in cholesterol and lipid metabolism, have also been 
reported to be involved in cell cycle regulation and diseases like type 2 diabetes, 
atherosclerosis, and obesity. Chromatin immunoprecipitation with microarray 
detection revealed that the binding sites for SREBP-1 are genes for host cell 
factor C1 (HCFC1) which is involved in cell cycle regulation, and for filamin A 
(FLNA). Binding of SREBP-1 and RNA polymerase II to HCFC1 and FLNA are 
also found to be sterol regulated. This indicates the possible role of SREBP-1 in 
cell cycle regulation other than lipid metabolism (Motallebipour et al., 2009). 
Besides having structural and signalling functions, lipids also work as energy 
reserves in the form of triacylglycerols (TAG). In budding yeast, it has been 
reported that TAG lipolysis by TAG lipase 4 (TGL4) is activated by Cdk1, and is 
necessary for bud formation. Failure of which would lead to delayed cell cycle 
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progression (Kurat et al., 2009). This highlights the importance of fatty acid 
storage in the form of TAG and its mobilisation during cell cycle for 
incorporation into phospholipids needed in membrane biogenesis.  
Fatty acids are carboxylic acids consisting of a hydrocarbon chain and a terminal 
carboxyl group. The availability of certain fatty acid species for lipid synthesis is 
critical in cell cycle progression. This is evident when the inhibition of stearoyl 
CoA desaturase-1 (SCD-1), the enzyme that produces monounsaturated fatty 
acids (MUFA), blocked cell cycle progression at G1/S and induced apoptosis in 
lung cancer cells. It was also observed that the phenotype could be rescued by 
addition of MUFAs, indicating that MUFAs are key molecules for cell 
proliferation. Hence, MUFA-mediated activation of lipid synthesis is essential for 
cell cycle progression (Hess et al., 2010). In addition, decreased ratio of 
arachidonic acid (a C20 fatty acid with four unsaturated bonds, abbreviated as 
20:4) to oleic acid (18:1) has also been reported to be important in regulating the 
physical properties of the cellular membranes during the cell cycle progression 
(Gross et al., 1988). 
Another evidence that fatty acid composition of lipids play a critical role in cell 
proliferation is that in ceramides. Ceramide (Cer) levels were reported to increase 
4- and 12- fold in benign and malignant breast tumor tissues respectively as 
compared to normal breast tissues. Specifically, C16:0, C24:1, and C24:0 Cer 
were significantly higher in malignant tumors (Schiffmann et al., 2009).  
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The relationship between lipids and cell cycle is complex. A brief overview of 















Figure 1.5 Main functions of lipids in the cell cycle. Lipids play three main 
roles in the cells, including energy storage, signalling and membrane structure. 
PM- plasma membrane; Golgi- Golgi Apparatus; MT- microtubules; Mito- 
mitochondria; LD- lipid droplets; ER- endoplasmic reticulum; Endo- endosome.  
TAG lipolysis by TGL4 
essential for S phase in 
yeast (Kurat et al., 
2009), this releases fatty 
acids for lipid synthesis 
to accommodate 
material demand during 
cell growth and division 
PE on cell surface at cleavage 
furrow during cytokinesis 
(Emoto et al., 2005)-molecular 
shape of PE enables membrane 
to bend at the furrow 
PI(4,5)P2 on at furrow 
membrane (Emoto et al., 2005) 
Presence of PIP2 in nucleus 
affects nuclear events (Ogiso et 
al., 2010)  
Cholesterol:phospholipid 
important in maintaining 
membrane viscosity for cell 
cycle progression (Cheng and 
Levy, 1979; Fernándeza et al., 
2004) 
PC as a mitogenic signal 
for cell proliferation 
(Podo et al., 2011) 
Signal transduction by 
PC for lipid synthesis 
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and Vance, 2004) 
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1.3 Rationale and objectives of this study 
 
One of the most intriguing biological processes is how mammalian cells divide. 
Implications of cell cycle research can be cast far and wide. Dysregulated cell 
division can lead to a whole myriad of diseases, including cancer, neurological 
diseases like Alzheimer’s disease (Nagy et al., 1998), renal (Shankland and Wolf, 
2000) and vascular proliferative diseases (Braun-Dullaeus et al., 1998).  
Although much work has been done in attempt to understand the role of lipids in 
cell cycle, not much has been carried out to provide an overview of lipid changes 
in cell division. Hence, the main objectives of this project are: 
(i) to obtain a comprehensive lipid profile of mammalian cells in different stages 
of the cell cycle, using an advanced, sensitive and accurate approach based on 
mass spectrometry; 
(ii) to identify lipid species which change in their abundance during the cell cycle 
and to analyse their role in cell cycle; 
(iii) to relate the findings to a pathological condition which involves dysfunctional 




2. MATERIALS AND METHODS 
The materials and methods stated here are common for all chapters. Additional 
relevant materials and methods can be found in each chapter. 
2.1 Materials 
Chloroform and methanol (HPLC grade) were from Merck (Merck Pte. Ltd., 
Singapore). Lipid standards, phosphatidylcholine (PC-14:0/14:0), 
phosphatidylethanolamine (PE-14:0/14:0), phosphatidylserine (PS-14:0/14:0), 
phosphatidic acid (PA-17:0/17:0), phosphatidylglycerol (PG-14:0/1(14:0), 
ceramide (C17-Cer), glucosylceramide (C8-GluCer), sphingomyelin (C12-SM), 
diacylglycerol (1:2-di-o-phytanyl-sn-glycerol/ DEDG), triacylglycerol (d5-TAG 
48:0), 7-keto-cholesterol-d7, 7-β-hydroxycholesterol-d7, 24-hydroxycholesterol-
d7 and zymosterol-d5, were obtained from Avanti Polar Lipids (Alabaster, AL, 
USA), except phosphatidylinositol (PI-8:0/8:0) from Echelon (Echelon 
Biosciences, Inc., Salt Lake City, UT, USA). Cholesterol-d6 and C18 cholesterol 
ester-d6 were obtained from CDN Isotopes (CDN Isotopes, Canada). Cell culture 
reagents including Dulbecco's Modified Eagle Medium (DMEM), penicillin-
streptomycin, glutamine and fetal bovine serum (FBS) were obtained from Gibco, 
Invitrogen. All other reagents, including aphidicolin, hydroxyurea, nocodazole, 
ammonium hydroxide (28% in water), and ammonium acetate were purchased 
from Sigma Aldrich (St. Louis, MO, USA), unless stated otherwise. 
2.2 Cell culture 
To obtain homogenous cell populations for all experiments, stocks of MCF7 and 
HeLa cells were stored in 90% fetal bovine serum (FBS) and 10% DMSO, and 
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preserved in liquid nitrogen at the start of the whole study. New cell stocks were 
used for each cell cycle synchronising and lipid profiling experiment. MCF7 and 
HeLa cells (ATCC) were routinely cultured in DMEM supplemented with 10% 
FBS, 100 units/ml penicillin-streptomycin and glutamine. Cells were incubated at 
37
o
C, in a humidified atmosphere under 5% carbon dioxide. Cells were subjected 
to cell cycle synchronisation at passage 4 for each experiment. 
2.3 Cell synchronisation 
Two chemical synchronisations were used in this thesis- aphidicolin and 
nocodazole. 
For the former synchronisation, 0.2 million MCF7 and HeLa cells were seeded 
into 10-cm dishes and synchronised at the G1/S phase with 5 µg/ml aphidicolin. 
The cells were subjected to aphidicolin treatment for 24 h, then released and 
collected at time points 0 and 10 h when the cells are at G1/S and G2/M 
respectively.   
Alternatively, cells were treated with 100 ng/ml nocodazole, which is a G2/M 
synchronizer. The cells were incubated with nocodazole for 12 h, then released 
and collected at the 0
th
 hour and 8
th
 hour for G2/M and G1 cells respectively. 
For cell collection at each time point, cells in each dish were washed twice and 
scrapped into ice-cold PBS. The cell suspension was then divided into three equal 
proportions for flow cytometric, protein and lipid analysis. 
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2.4 Flow cytometric analysis 
DNA of cells was stained with propidium iodide. Cells were collected and washed 
several times with PBS. Following that, the cells were fixed in prechilled 70% 
ethanol overnight at 4
o
C. Cells were subsequently stained with DNA staining 
solution (25 µg/ml of propidium iodide, 200 µg/ml RNase A and 0.1% Triton X-
100) and incubated in the dark for at least 30 minutes. The stained cells were then 
filtered through 60 µm pore-size nylon mesh to ensure a single cell suspension 
and subjected to analysis by flow cytometer FACS Calibur (Becton Dickinson, 
Mountain View, CA, USA) at an excitation wavelength of 488 nm and emission 
wavelength of 630 nm. Ten thousand cells in each sample were analysed and the 
proportion of cells at different phases of the cell cycle was calculated by FlowJo® 
(Tree Star, Inc). 
2.5 Immunoblot analysis 
To complement the flow cytometric data, western blots on cyclins (Cell Signaling) 
were conducted on the samples.  Cells were lysed in RIPA buffer (50 mM Tris 
HCl pH 7.4, 1% NP-40, 150 mM NaCl, 1 mM EDTA and protease inhibitor 
cocktail (Roche)). The protein amount was quantified by Bio-Rad (Hercules, CA, 
USA) DC Protein Assay, based on the method of Lowry. Approximately 20 µg 
protein of each cell lysate was subjected to SDS-PAGE (10%) in Mini-
PROTEAN III system (Bio-Rad), and then electrophoretically transferred to 
nitrocellulose membrane (Bio-Rad). After blocking with 5% non-fat milk (Bio-
Rad) in TBST (10 mM Tris-HCl, pH 7.5, 100 mM NaCl and 0.1% Tween-20), the 
membrane was probed with antibodies and developed with enhanced 
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chemiluminence (Pierce, IL, USA) system using X-ray (Kodak Minolta, SRX-
101A). Protein markers from BioRad or Fermantas were used as references. 
2.6 Lipid analysis 
2.6.1 Lipid extraction 
Lipids were extracted using the modified Bligh and Dyer’s method (Bligh and 
Dyer, 1959). Briefly, 750 µl of ice cold chloroform: methanol (1:2, v/v) was 
added to cells that were scraped down and resuspended in 200 µl of PBS. The 
mixture was vortexed vigorously for 1 min. After vigorous shaking for 1 h, 250 l 
ice cold chloroform and 350 l of ice cold water was added to the samples. The 
samples were then subjected to another 2 min of vortexing. The phases were 
separated at 9000 × g and the lower organic phase containing the lipids was 
transferred to a fresh tube. Lipids were re-extracted from the remaining aqueous 
phase with 500 l of ice cold chloroform after another 10 min of vigorous shaking. 
The two extracts were pooled and vacuum-dried. Dried lipid film was then 
reconstituted in chloroform: methanol 1:1 (v/v) prior to analysis by mass 
spectrometry. The volume used for reconstitution of each sample was based on 
the respective sample’s protein concentration. The lipid samples were spiked with 
a mixture of internal standards prior to mass spectrometry. The standard cocktail 
contained PA-14:0/14:0, PE-14:0/14:0, PG-14:0/14:0, PI-8:0/8:0, PS-14:0/14:0, 
PC-14:0/14:0, C-17 Cer, C8-GluCer, C-12 SM for polar lipids, and  d5-TAG 48:0, 
DEDG, cholesterol-d6, C18 cholesterol ester-d6, 7-keto-cholesterol-d7, 7-β-




2.6.2 HPLC-MS profiling of diverse lipids 
Quantification of individual lipid molecular species was performed as described 
(Shui et al., 2011b) using multiple reaction monitoring (MRM) on an ABI 3200 
triple quadrupole instruments (Applied Biosystems, Foster City, CA). Briefly, 
individual classes of polar lipids were separated using an Agilent 1200 high 
performance liquid chromatography (HPLC) system before introduction into the 
mass spectrometer. HPLC conditions were: Luna 3-µm silica column (i.d. 150 x 
2.0 mm); mobile phase A (chloroform:methanol:ammonium hydroxide, 
89.5:10:0.5), mobile phase B (chloroform:methanol:ammonium hydroxide:water, 
55:39:0.5:5); flow rate 300 µl/min. The separation was carried out using a 
gradient starting with 5% mobile phase B for 3 min, then linearly ramping to 30% 
mobile phase B over 24 min and maintaining for 5 min; the gradient was then 
ramped linearly to 70% mobile phase B over 5 min and maintained for 7 min. The 
composition of mobile phase was then returned to the original 5% mobile phase B 
over 5 min and maintained for 6 min before the next sample was analysed. MRM 
transitions for individual glycerophospholipids (PG, PE, PC, PI, PS and PA) and 
sphingolipids (SM, Cer and GluCer) were set up at different elution stages for 
liquid chromatography (LC)-MS analysis in both positive and negative modes 
with separate runs. Whereas PG, PI, PS and PE were separated and quantified in 
the negative ESI mode, Cer, GluCer, PC, SM and LysoPC were separated and 
quantified in the positive ESI mode.  
TAG and DAG were analysed using a reverse-phase LC-MS approach as 
described (Shui et al., 2010) with slight modification. Briefly, TAG and DAG 
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were separated from polar lipids on Phenomenex Kinetex 2.6 µ-C18 column (i.d. 
4.6 x 100 mm) with chloroform:methanol:0.1M ammonium acetate (1:1:0.04) as a 
mobile phase at a flow rate of 0.18 ml/min. Selective ion monitoring was used to 
record the various TAG and DAG species. TAG and DAG concentrations were 
calculated by normalising to spiked internal standards d5-TAG and DEDG and 
then further normalised to the total polar lipids in the respective samples. 
Sterol lipids were analysed as described (Shui et al., 2011a) using reverse-phase 
HPLC atmospheric pressure chemical ionisation (APCI) MS. The separation was 
carried out using an Agilent Zorbax Eclipse XDB-C18 column and mobile phase 
containing chloroform:methanol (1:1, v:v) at a flow rate of 500 µl/min. The 
instrument was operated in the positive mode with a vaporizer temperature of 
500ºC and corona current of 3 μA. Each sterol species was quantified relative to 
spiked internal sterol lipid standard, and then normalised to the total polar lipids 
in the sample. 
2.7 Data analysis 
MRM data were extracted based on lipid class using Analyst Software (Applied 
Biosystems, Foster City, CA, USA), converted into text format. The data were 
normalized by the spiked standard concentration followed by normalization by 
total number of moles made to unity. The data were then filtered for noise by 
deleting first the lipids which showed very low or no counts. Mann-Whitney U 
test was carried out to identify significant lipids (p-value<0.05) using statistical 
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 3. CELL CYCLE SYNCHRONISATION AND LIPID PROFILE 
3.1 Cell cycle synchronisation 
Cell cycle synchronisation involves the enrichment of cells in specific cell cycle 
phases. This is be achieved by separating the cells based on their physical 
properties such as size (physical synchronisation method) or perturbing the cell 
cycle progression biochemically (chemical synchronisation method). One 
common property among all methods is that there will be contamination of cells 
from other cell cycle phases. However, the former method is more advantageous 
as the cells are not exposed to pharmacological agents which may have unknown 
effects on cell metabolism. Some of the physical methods of synchronisation 
include serum deprivation, centrifugal elutriation, mitotic shake-off or cell sorting 
(Davis et al., 2001). Centrifugal elutriation separates cells in a particular phase of 
the cell cycle from an asynchronous population based on size and density. Early 
G1 cells are smaller, about half the size of cells in the late G2/M phase, while S 
phase cells are intermediate (Banfalvi, 2011). The advantages of centrifugal 
elutriation include (i) no requirement of prior pharmacological treatment or 
culture stress like starvation; (ii) ability to acquire cell populations from any phase 
of the cell cycle and obtain a large amount of phase-specific cells for subsequent 
analysis; (iii) high reproducibility. Mitotic shakeoff is a non-disruptive method for 
isolating mitotic cells. Cells entering mitosis in adherent cultures often round up 
and become loosely attached to the culture plates. These cells can then be isolated 
by tapping the plates repeatedly over a period of time. The medium containing 
these mitotic cells is subsequently transferred to another culture plate where the 
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cells are allowed to attach upon G1 entry (Fox, 2003). Serum deprivation drives 
the cells into quiescent G0 state, and upon addition of serum, the cells would enter 
the cell cycle at G1. However, it has been reported that, as cells progress through 
the cell cycle into late G1 and S phase following serum addition, the different 
progression rates within the cell population continue to increase, resulting in a 
rapidly unsynchronised population of cells (Davis et al., 2001). 
Pharmacological agents, like thymidine, aphidicolin and nocodazole, that arrest 
cells at specific cell cycle phases are often used for chemical synchronisation 
purposes. One of the advantages of using these agents is that specific cell cycle 
stages could be targeted and studied. A population of highly synchronised cells 
can also be achieved. For instance, cells can be arrested in S phase by thymidine 
or hydroxyurea treatment by targeting ribonucleotide reductase which is essential 
in DNA synthesis in S phase. However, the flip side of this method is that cell 
metabolism may be perturbed, resulting in toxicity and cell death (Davis et al., 
2001). 
For this study, large number of synchronised cells are needed for flow cytometric, 
protein and lipid analysis. Hence, the cell synchronisation method has to 
consistently provide substantial numbers of synchronised cells, with minimal 
disturbance to the lipid metabolism. In order to find the most appropriate method 
for this study, several methods were evaluated (Table 3.1). The first three 
methods, ie. mitotic shakeoff, centrifugal elutriation and flow cytometry based 
sorting, would be the most ideal as they do not involve any chemical intervention. 
However, they were not feasible as their throughputs were too low for subsequent 
 30 
 
flow cytometric, lipid and protein analysis. The fourth method, ie. 
pharmacological, which involves chemical intervention, provided the highest 
throughput and  high reproducibility. Concerns over the possible metabolic 
perturbations by the drugs could be addressed by optimising the drug 
concentration and the treatment duration. In this study, pharmacological methods, 
mainly aphidicolin and nocodazole, were applied to synchronise cells. 
Aphidicolin blocks cells at G1/S border by reversibly inhibiting DNA polymerase 
alpha (Pedrali-Noy et al., 1980). Nocodazole, on the other hand, traps cells in 
mitosis (prophase to pseudometaphase) by affecting the spindle microtubule 
dynamics (Ma and Poon, 2011). 
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Table 3.1 A summary of four common methods used in cell synchronisation, and the advantages and problems 
faced while trying each method during this experimental work. 
 
Method Brief Description Advantages Problems faced in this study
Mitotic Shakeoff Mitotic cells were shaken off and plated 
onto a fresh plate.
No chemical intervention. Large amounts of starting 
material, little yield.




Cells were separated based on their size 
and density 
which correlate to the different cell 
cycle stages.
No chemical intervention.
Can achieve high purity.
Allows the selection of
cells during the whole 
cell cycle.
Large amounts of starting 
material, little yield.
Only managed to obtain G1 cells.
Flow cytometry
based sorting
Live cells were DNA-stained with dyes 
(Vybrant DyeCycle) and sorted 
according to their DNA content.
Can achieve high sample 
purity.
Large amounts of starting 
material, little yield.







Cells were treated with drug that could 
arrest them at specific cell cycle stage 
without any effect on the cell viability.
Can constantly achieve
high quantity of 
synchronised cells. 
Good sample purity (60-
80% synchronisation)
Cells died when treated with 
certain drugs like nocodazole. 
This was solved by using a lower 




3.2 Platform for cellular lipidomics setup and analysis 
3.2.1 Cell number versus total lipid 
Since this study involves analysing lipid changes in the cell cycle, method for 
lipid data analysis needs to be standardised. For instance, in the case of cell cycle 
synchronisation of x number of cells at G2/M and then release into G1 of the next 
cycle, cell numbers (in x) would have doubled in G1 samples (ie. 2x) compared to 
the original G2/M samples (ie. x), assuming all cells would have undergone 
mitosis in the G2/M samples after release from G2/M synchronisation. Hence, if 
we extract the data directly from the samples without normalisation to the cell 
number, we would see an inevitable increase in lipid counts in G1 compared to 
G2/M. This is due to the different number of cells in each sample, and is not an 
accurate representation of lipid changes in a cell as the cell divides. 
Counting cell numbers would be the most direct way to normalise raw lipid signal 
intensities. However, this may not be the best and accurate way as cell size varies 
considerably in culture. Bigger cells would presumably have more lipids than 
smaller cells. Therefore, raw lipid signal intensities have to be normalised against 
a reliable parameter which is reflective of the cell number. Normalisation against 
DNA content is not viable as DNA content changes in the cell cycle. In G2/M 
cells, the double copy of DNA in one cell is also equivalent to DNA content of 
two G1 cells, and cannot be differentiated by just DNA concentration. 
Normalisation by protein content may be more reliable, however, it is subjected to 
many other variables, such as the types of protein present in different stages of the 
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cell cycle and the number of cells taken for protein estimation and for lipid 
analysis. 
To take into account this effect, we hypothesised that the most straightforward 
method of normalisation would be to normalise the signal intensity of each lipid 
species against total lipid intensities (of both positive and negative ESI mode) in 
each sample run. This would give us a better indication of the proportionate 
change of each lipid per weight of lipids. An experiment was thus carried out to 
determine the relation between the cell number and the total lipid signal 
intensities. Using HeLa as a cell model, the cell numbers were plotted against the 
respective total lipid signal intensities (Figure 3.1). It is observed that the 
relationship between cell numbers and total lipid counts is linear from 0.25 to 1 
million cells. The average doubling times for MCF7 and HeLa cells are 24 h and 
29 h respectively (ATCC, Manassas, VA). The whole duration of the experiments 
from cell seeding to collection takes up to 50 h. Hence, for the subsequent 
experiments, cells were seeded at 0.2 million in 10-cm dishes such that they 







Figure 3.1 Graph representing the relationship between cell number and log 
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3.2.2 FBS effect on general lipid profile 
FBS is obtained from clotted blood of the bovine fetus. It contains many factors 
that are needed for survival and propagation of mammalian cell culture. Its 
commercial availability, and its known ability to keep cells viable and healthily 
growing, made it popular. Although FBS has been widely used by researchers all 
over the world to supplement their cell culture, it has been generally accepted that 
the composition of FBS in the cell culture media can affect the outcome of 
experiments. Reported work on FBS composition impact on cell metabolism, in 
particular lipids, is very scarce however. It was previously reported that different 
FBSs contain distinct fatty acid compositions at the phospholipid level (Lagarde 
et al., 1984). Recently, Marazzi et al reported that the endocannabinoid content of 
FBS can directly affect the function of monocytes/macrophages, and 
osteoclastogenesis, thereby contributing to unwanted and unexpected variations 
between experiments and laboratories. Major endocannabinoids can act as full 
and partial agonists at several receptors (eg. PPAR) implicated in many metabolic 
pathways (Marazzi et al., 2011). 
As FBS is also used in this study as a supplement in culture media routinely at 
10%, experiments were done on HeLa cells to observe if there is any influence on 
the phospholipid composition in cells grown in media with different FBS 
percentages over different incubation times (Figure 3.2). It is demonstrated here 
that there were no significant differences in the lipid profile among cells exposed 
to different percentages of FBS over 24, 48 and 72 hours. This finding indicates 
that the changes in the lipid profile over time which we will observe later in the 
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cell cycle study are not likely to be affected by the presence of FBS and the 
duration of growth in culture. 
 
Figure 3.2 Heatmap of lipid fold changes in HeLa cells cultured in media 
with different FBS percentage for 24, 48 and 72 hours, as compared to the 







































































































































































































































































0h 24h 48h 72h
Duration which the cells were grown
FBS percentage in media
 37 
 
3.3 Materials and Methods 
Having established the platform for cell cycle synchronisation and lipid analysis, 
we progressed on our study about lipid changes during the cell cycle. Figure 3.3 
summarises the main steps involved in the study. Overall, two synchronisation 
methods, aphidicolin and nocodazole, were applied on two cell lines, MCF7 and 
HeLa (human cervical cancer). The detailed materials and methods can be found 
in Chapter 2. 
 
Figure 3.3 Schematic diagram of the work flow of cell cycle synchronisation 
and sample collection. (A) Aphidicolin synchronisation and release for sample 
collection. (B) Process of cell synchronisation and release from nocodazole. In 
both (A) and (B), cells were collected at two time points, namely 0 h (from Plate 1) 
and 8 or 10 h (from Plate 2). Cells from each plate were then divided into three 
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3.4.1 Phospholipid profile of the cell cycle 
3.4.1.1 Aphidicolin synchronisation and lipid profile of MCF7 cell cycle from 
G1/S to G2/M 
 
MCF7 cells were synchronised at G1/S using aphidicolin, then released and 
collected after 10 h when majority of the cells had entered G2/M. Flow cytometric 
or FACS analysis was done to confirm the cell cycle stages based on the DNA 
content (Figure 3.4A). At 0 h, the cells were synchronised at G1/S. By the 10
th
 
hour, most cells entered G2/M (Figure 3.4B). FACS data indicating the cell cycle 
phases were confirmed by western blots of cyclins B and E. Higher levels of 
cyclin B at the 10
th
 hour and cyclin E at the 0
th
 hour supported the FACS data 






Figure 3.4 Cell cycle analysis of MCF7 cells synchronised at G1/S by 
aphidicolin and then released into G2/M. (A) Flow cytometry histogram 
illustrating the distribution of MCF7 cells in different phases of the cell cycle 
after aphidicolin synchronisation and release. (B) Plots representing the mean 
proportion of cells in different phases of the cell cycle for cells released after 0 
and 10 hours. Error bars represent + SD (standard deviation). n=3, *p<0.05. (C) 
Western blot analysis of cyclins to determine the cell cycle stages. GAPDH serves 
as a loading control. APH 0h and APH 10h indicate cells that had been released 




Key Name Parameter Gat
MA1 0h FL2-A G2
MA2 10h FL2-A G2




























































The lipid changes between G1/S and G2/M MCF7 cells were represented as a 
heatmap of averaged intensities of individual lipid species (species average) 
versus the moving average (Figure 3.5). The moving average is obtained by 
taking the average of signal intensities of each lipid species across all time points. 






Figure 3.5 Heatmap representation of individual polar lipid species changes 
in MCF7 cells released from aphidicolin synchronisation. Amount (µg/ml) 
percentage of individual lipid species was averaged across time to obtain the 
moving average value. The log10 ratio was then calculated for signals of each 
lipid species for each time point normalised to the moving average. MCF7 cells 
were synchronised at G1/S by aphidicolin, and then released up to 10 h, when 
most cells were in G2/M. oPC- PC with odd number of fatty acids; LPC- lysoPC. 





































































































































































































Out of 127 lipid species measured and analysed, about 30 lipids showed 
significant (p<0.05) differences between G1/S and G2/M cells. Figure 3.6 shows 
the trends and extent of change in the 30 lipids. Most of the significant lipids (PG 
and PC) showed an increasing trend. 
 
Figure 3.6 Bar graph of fold change in lipids that were significantly (p<0.05) 
changed as MCF7 cells progressed from G1/S to G2/M after being released 





3.4.1.2 Aphidicolin synchronisation and lipid profile as HeLa cells progressed 
from G1/S to G2/M 
 
In order to confirm that the lipid changes in cell cycle are not specific only to 
MCF7, HeLa cells were also synchronised and analysed for lipids. HeLa cells 
were treated similarly as MCF7, as described in the previous section. The duration 
at which HeLa cells took to progress from one cell cycle phase to the next was 
similar to that of MCF7.  
Figure 3.7 depicts the cell cycle analysis of HeLa synchronised and released from 
aphidicolin. Based on FACS diagram in Figure 3.7A, most cells were in G1/S 
phase at the 0
th
 hour and progressed into G2/M at the 10
th
 hour. Cyclins were 
analysed using western blot to support the FACS output (Figure 3.7C). Indeed, 
higher amount of cyclin E and lower amount of cyclin B were expressed 
immediately after aphidicolin release (0 h), indicating that the cells were at G1/S. 
At the 10
th
 hour, the cells expressed more cyclin B and less cyclin E, proving that 





Figure 3.7 Cell cycle analysis of HeLa cells synchronised and released from 
aphidicolin. (A) Flow cytometry histogram illustrating the distribution of HeLa 
cells in different phases of the cell cycle after aphidicolin synchronisation and 
release. (B) Mean proportion of cells in different phases of the cell cycle at 0 h 
and 10 h upon release from aphidicolin. Error bars represent + SD. n=3, *p<0.05. 
(C) Western blot analysis of cyclins to determine the cell cycle stages. GAPDH 
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Synchronised HeLa cells were then subjected to lipid analysis. Figure 3.8 shows 
the heatmap of species average versus moving average in log scale in G2/M 
against G1. As with MCF7, an increase in several PC species can be detected. 
Most of the significant lipids that change in HeLa from G1/S to G2/M were PCs 
(Figure 3.9), and majority of these PCs are also significant in aphidicolin 
synchronised MCF7 cells in Figure 3.6. In addition to the PCs which were 
observed in MCF7 cells, ether PCs (denoted by 'p's and 'e's) were also 
significantly changed in HeLa cell cycle. While the shorter chain (C32-C36) ether 





Figure 3.8 Heatmap representation of individual polar lipid species changes 
in HeLa cells released from aphidicolin synchronisation. Log ratio (species 
average/moving average) was calculated and plotted. HeLa cells were 
synchronised at G1/S by aphidicolin, and then released up to 10 h, when most 
cells were in G2/M. ePE/ePC- PE/PC with an ether linkage. Yellow represents 

































































Figure 3.9 Bar graph of fold change in phospholipids that were significantly 
(p<0.05) changed as HeLa cells progressed from G1/S to G2/M after being 





3.4.1.3 Nocodazole synchronisation and lipid profile of MCF7 cells from 
G2/M to G1 
 
Nocodazole G2/M synchronisation and release to G1 offers another perspective 
for cell cycle lipid changes. MCF7 cells were synchronised at G2/M by 
nocodazole and then released and collected at 8 h, when most of the cells entered 
G1 (Figure 3.10). FACS data and cyclin protein expressions complemented each 
other, indicating the cells were in G2/M and G1 at 0 h and 8 h respectively 
(Figure 3.10). 
 
Figure 3.10 Cell cycle analysis of MCF7 cells synchronised by nocodazole and 
released. (A) Flow cytometry histogram illustrating the distribution of MCF7 
cells in different phases of the cell cycle after nocodazole synchronisation and 
release. (B) Mean proportion of cells in the respective phases of the cell cycle 
after 0 and 8 hours upon release from nocodazole synchronisation. Error bars 
represent + SD. n=3, * p<0.05. (C) Western blot analysis of cyclins to determine 
the cell cycle stages. GAPDH was used as a loading control. NOCO 0h and 
NOCO 8h represent cells that were released from nocodazole synchronisation for 
0 h and 8 h respectively. 
Key Name Parameter Gat
MN1 8h FL2-A G2
MN1 0h FL2-A G2



























































Lipids were then extracted from the nocodazole-synchronised MCF7 cells and 
subjected to lipid analysis. Based on the heatmap in Figure 3.11, we observe less 
drastic changes in the lipid species as cells progressed from G2/M to G1, as 
compared to aphidicolin synchronisation. This may imply that most of the lipid 
changes take place from G1 to G2/M rather than from G2/M to G1, indicating that 
the lipidomics of the cells do not change much during division or after the cells 






Figure 3.11 Heatmap representation of individual polar lipid species changes 
in MCF7 cells released from nocodazole synchronisation. MCF7 cells were 
synchronised at G2/M by nocodazole, and then released up to 8 h, when most 
cells were in G1. Yellow represents values higher than moving average, while 



































































































































































Among the lipids that were analysed, 49 lipids displayed significant differences 
(p<0.05) in G2/M and G1 cells. Figure 3.12 shows in greater detail the log fold 
change in the significant lipids. These lipids belonged mainly to PI, PC, PG and 
SM. Although significantly different between the two groups of cells, the extent 
of fold change is less pronounced than that in aphidicolin synchronised cells. 
Some PC species were significantly lower in G1, while others were higher. A 
decreasing trend was observed for several PI species in G1, while an increasing 
trend was observed for SM and PG. 
 
Figure 3.12 Bar graph of fold change in lipids that were significantly (p<0.05) 
changed as MCF7 cells progressed from G2/M to G1 after being 





3.4.1.4 Nocodazole synchronisation and lipid profile as HeLa cells 
progressed from G2/M to G1 
 
Similar with MCF7, HeLa cells were also subjected to nocodazole 
synchronisation. HeLa cells were indeed arrested at G2/M upon nocodazole 
release at 0h, and then subsequently entered into G1 at the 8th hour post release 
(Figure 3.13A and B). Western blots of representative cyclins were also 
conducted to confirm various cell cycle stages. Cyclin B was probed to prove 
G2/M stage while cyclin E was probed for G1/S. Cells were noted to exit G2/M 
and enter G1 at the 8th hour (Figure 3.13C). 
 
Figure 3.13 Cell cycle analysis of HeLa cells synchronised and released from 
nocodazole. (A) Flow cytometry histogram illustrating the distribution of HeLa 
cells in different phases of the cell cycle after nocodazole synchronisation and 
release. (B) Mean proportion of cells in respective cell cycle phases at 0 and 8 h 
upon release from nocodazole treatment. Error bars represent + SD. n=3, *p<0.05. 
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(C) Western blot analysis of cyclins to determine the cell cycle stages. GAPDH is 
used as a loading control. 
Lipid analysis was then carried out on these two groups of synchronised cells. 
Figure 3.14 illustrates the heatmap of the average of each lipid species in two time 
points (0 h and 8 h) with respect to the moving average of all the samples in both 
time points. As observed in MCF7 cells, the changes were less drastic in G1 HeLa 
cells which originated from G2/M. Figure 3.15 shows the exact fold change of 
individual species which were shown to be significant (p<0.05) between G1 and 
G2/M HeLa cells, and the changes were generally smaller compared to when cells 
progressed from G1/S to G2/M. Like in MCF7 cells, levels of significant PI 








Figure 3.14 Heatmap representation of individual polar lipid species changes 
in HeLa cells released from nocodazole synchronisation. HeLa cells were 
synchronised at G1/S by nocodazole, and then released up to 8 h, when most cells 
were in G2/M. Yellow represents values higher than moving average, while blue 


































































Figure 3.15 Bar graph of fold change in lipids that were significantly (p<0.05) 
changed as HeLa cells progressed from G2/M to G1 after being synchronised 





3.4.1.5 Trends in overall phospholipids 
 
The purpose of using two cell lines from different origins, namely HeLa and 
MCF7 of cervical and breast origins respectively, is to provide us an unbiased 
perspective in cell cycle-related lipid changes. Figure 3.16 shows the overall view 
of common lipid species which showed similar trends in both cell lines in 
different stages of the cell cycle. In both cell lines, PC increased as cells 
progressed from G1/S to G2/M. On the other hand, PI and SM levels were lower 
and higher respectively in G1 compared to G2/M.  
 
Figure 3.16 Venn diagrams summarising the overall similar lipids that 
display the same trends in both cell lines. (A) Common lipids that showed 
significant (p<0.05) trends in aphidicolin synchronised HeLa and MCF7 cells. 
Most of the lipid species were PC and they showed increased levels in G2/M. (B) 
common lipids that showed significant changes in nocodazole  synchronised 
HeLa and MCF7 cells. There were mainly two groups of lipids that were 
consistent between the two cell lines- PI which were decreased and SM which 





In Chapter 3.2.2, lipid percentage changes in HeLa cells incubated in media with 
10% FBS for 24 h (Figure 3.2) were plotted in the heatmap. The average 
percentage change of the lipids was approximately 25%. This suggests that 25% 
change in lipid signal intensities may be inherent in certain lipid species in cell 
culture. Hence, a more in-depth analysis was done by setting the fold change 
threshold at +/- 25% (Table 3.2) for lipid changes in the cell cycle to be 
considered significant. With this analysis, PC remained the main player in both 
cell lines in the progression of cell cycle from G1/S to G2/M. PI also changed 






Table 3.2 In depth analysis of the fold change of lipids in both cell lines for both synchronisation methods. Table 
showing the proportion of significant lipids with an average log fold change of more than + 0.1 (which is equivalent to 
a fold change of approximately + 25%) when HeLa and MCF7 cells were released into G2/M from G1/S Aphidicolin 
synchronisation and G2/M to G1 from nocodazole synchronisation. All lipids analysed here have even carbon chain 
length except for oPC. (aPC/aPE- diacyl PC/PE; ePC/ePE-ether linked PC/PE; oPC- PC with odd carbon number in one 
of the fatty acid chains) 
 
  
From G1/S to G2/M From G2/M to G1

















































PG 8 3 1 14 9 7 8 2 2 14 5 3
PI 17 6 0 19 1 1 17 8 3 19 6 2
PS 12 2 0 12 0 0 12 1 0 12 1 0
aPE 20 3 0 20 0 0 20 1 0 20 1 0
ePE 12 1 0 0 0 0 12 1 0 0 0 0
aPC 25 11 6 26 12 3 25 14 2 26 14 0
ePC 18 5 4 0 0 0 18 9 1 0 0 0
oPC 18 7 5 19 8 4 18 6 3 19 6 0
SM 13 0 0 17 0 0 13 3 0 17 16 0
Total 143 38 16 127 30 15 143 45 11 127 49 5
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Although the levels of many lipid species changed during the cell cycle, the 
overall abundance of each lipid class remained similar under both synchronisation 
methods for both HeLa (Figure 3.17) and MCF7 (data not shown) cells. This is 
probably due to the net effect of decreasing and increasing lipid species in each 
class. This may indicate that the total amount of lipids in each class is tightly 
regulated, and it is the changes in individual species with specific fatty acid 
composition that may play important roles in the cell cycle. 
 
 
Figure 3.17  Bar charts showing the sum of each lipid class. Both aphidicolin 
(A) and nocodazole (B) synchronised HeLa cells showed no significant change in 







































































































To determine whether the degree of unsaturation in fatty acid is critical for cell 
cycle, the lipids were grouped according to the total number of double bonds in 
the two fatty acyl chains. Despite monounsaturated lipids being the most abundant 
species, no significant change in their levels could be observed in the cell cycle. 
Instead, there was a significant increase in the levels of lipids with three to five 
double bonds when the aphidicolin synchronised cells progressed from G1/S to 
G2/M. However, similar observations were also made in nocodazole synchronised 
cells progressing from G2/M to G1/S (Figure 3.18). This may indicate that the 
changes in fatty acid degree of unsaturation are not cell cycle mediated. 
 
Figure 3.18 Bar charts showing trends in the total degree of unsaturation in 
fatty acyl chains in cell cycle for aphidicolin (A) and nocodazole (B) 
synchronised HeLa cells. Polyunsaturated fatty acids were significantly 
increased in both synchronisation methods, indicating that fatty acid degree of 



















































































3.4.2 Neutral lipid profile 
3.4.2.1 TAG and DAG 
 
Apart from serving structurally in membranes and being involved in various 
signalling pathways, lipids work as energy reserves as they are stored in the form 
of TAG in cytosolic lipid droplets. Upon energy demand, TAG stores are then 
immobilised (Lass et al., 2011). 
TAG and DAG metabolism has been linked to cell cycle. A protein called G0/G1 
switch gene 2 (G0S2) was identified as a selective inhibitor of adipose 
triglyceride lipase (ATGL) (Yang et al., 2010). G0S2 was found to be expressed 
during the reentry of mononuclear cells from G0 into G1 phase of the cell cycle 
(Russell and Forsdyke., 1991). It was also identified as a mitochondrial protein, 
which interacts with Bcl-2, thus altering mitochondrial membrane permeability 
and promoting apoptosis. G0S2 is postulated to be the link between lipolysis and 
many other cell processes like cell cycle, survival and death. In yeast, it was 
observed that the activity of major triacylglycerol lipase, TGL4, a yeast 
orthologue of human AGTL, is closely linked to S phase entry (Kurat et al., 2009).  
We thus looked into TAG and DAG content of the cells with cell cycle progress.  
3.4.2.1.1 From G1/S to G2/M 
  
Figure 3.19 and 3.20 show the DAG and TAG profile of MCF7 and HeLa cells 
respectively as they progressed from G1/S to G2/M after release from aphidicolin 
synchronisation. In both cell lines, no common trend among the individual DAG 
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and TAG species could be observed. Furthermore, there was no significant 
difference in the total DAG and TAG for both HeLa and MCF7 in the two 
different cell cycle phases. 
 
 
Figure 3.19 Changes in DAG and TAG as MCF7 progressed from G1/S to 
G2/M. DAG and TAG levels at G2/M were normalised against those at G1/S. (A) 
Heatmap of individual species of DAG and TAG changes in the cell cycle, using 
G1/S as a reference. (B) Bar graph showing the average fold change of total DAG 




























































































































Figure 3.20 Changes in DAG and TAG as HeLa progressed from G1/S to 
G2/M. DAG and TAG levels at G2/M were normalised against those at G1/S. (A) 
Heatmap of individual species of DAG and TAG changes in the cell cycle, using 
G1/S as a reference. (B) Bar graph showing the average fold change of total DAG 





























































































3.4.2.1.2 From G2/M to G1 
 
Figure 3.21 and 3.22 display DAG and TAG changes in MCF7 and HeLa cells 
respectively, as they progressed from G2/M to G1 upon release from nocodazole 
G2/M synchronisation. Similar to the case in G1/S to G2/M from aphidicolin 
synchronisation, there is no common trend in DAG/TAG changes in both cell 
lines. Also, total DAG and TAG levels remained constant between the two cell 
cycle stages. 
 
Figure 3.21 Changes in DAG and TAG as MCF7 progressed from G2/M to 
G1. DAG and TAG levels at G1 were normalised against those at G2/M. (A) 
Heatmap of individual species of DAG and TAG changes in the cell cycle, using 
G2/M as reference. (B) Bar graph showing the average fold change of total DAG 

























































































































Figure 3.22 Changes in DAG and TAG as HeLa cells progressed from G2/M 
to G1. DAG and TAG levels at G1 were normalised against those at G2/M. (A) 
Heatmap of individual species of DAG and TAG changes in the cell cycle, using 
G2/M as reference. (B) Bar graph showing the average fold change of total DAG 






















































































































As a major component of mammalian cell membranes, cholesterol is essential for 
cell growth. It influences the rigidity and fluidity of the membrane lipid bilayer, 
which in turn changes during the cell cycle, with greater microviscosity in G2 and 
M phase (de Laat et al., 1977). 
Cholesterol synthesis has been closely associated with cell proliferation. For 
instance, cholesterol synthesis was reported to increase by six folds in 
phytohemagglutinin stimulated mouse lymphocytes before S phase entry (Chen et 
al., 1975). In synchronised BHK 21 cells, cholesterol synthesis peaked during G1, 
concurrent with the activation of HMG-coA reductase (Quesney-Huneeus et al., 
1979). Besides increase in de novo synthesis, cholesterol uptake via LDL 
receptors is also elevated (Vitols et al., 1994). It has also been reported that 
cholesterol is essential for the transition from G2 to M through its effects on 
p34cdc activity in MOLT-4 and HL-60 cells (Martinez-Botas et al., 1999). 
Here, we analysed the levels of cholesterol and other sterol derivatives, including 
cholesterol esters, 24- and 7-hydroxyl (OH) cholesterol, 7-keto cholesterol, 
squalene and zymosterol during the cell cycle in both MCF7 and HeLa cells.  
3.4.2.2.1 From G1/S to G2/M 
 
Figure 3.23 shows the average fold change of each sterol in G2/M against G1/S in 
aphidicolin G1/S synchronised cells. Overall, there was no significant change in 
the levels of cholesterol and its derivatives, except for cholesterol esters. In both 
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HeLa and MCF7, the level of cholesterol esters were higher in G2/M as compared 
to G1. This effect is stronger in HeLa cells where the magnitude of increase is 
almost 1.5 fold (Figure 3.23B). 
 
Figure 3.23 Fold changes in cholesterol and its derivatives in G2/M cells 
compared to G1/S in (A) MCF7 and (B) HeLa, as the cells progressed from 
G1/S to G2/M after aphidicolin synchronisation. n=6 for MCF7; n=9 for HeLa. 
*p<0.05. (CE- cholesterol ester; 24-OH- 24OH cholesterol; 7-OH- 7-OH 
















































































3.4.2.2.2 From G2/M to G1 
 
On the other hand, when nocodazole-synchronised cells progressed from G2/M to 
G1, cholesterol ester and squalene decreased significantly (p<0.05) for MCF7 
cells. Cholesterol esters levels were decreased by an average of 22%. However, 
no significant change was observed in HeLa cells (Figure 3.24). Nevertheless, the 
opposite trends in cholesterol ester from G1/S to G2/M and from G2/M to G1 are 
interesting as this underlies the possible importance of cholesterol ester in the cell 





Figure 3.24 Fold changes in cholesterol and its derivatives in G1 cells 
compared to G2/M in (A) MCF7 and (B) HeLa, as the cells progressed from 















































































The cellular lipidome, in particular that of mammalian cells, consists of tens of 
thousands of distinct lipid molecular species (Dennis, 2009). One of the major 
challenges in mass spectrometry of lipids is to comprehensively measure the 
lipidome of a biological material in one experiment. Even with major advances in 
mass spectrometry technologies, detection of lipid species of very low abundance 
still poses a challenge to the field (Wenk, 2010). The dynamic metabolism of 
lipids, with the organization and tight regulation of the biological membrane, 
make it even harder to detect important subtle changes which might have 
significant biological impact. 
In the present study, whole-cell extracts were used. While this provides a global 
lipid profile, it may lead to the loss of spatial distribution of cellular lipids. Lipid 
functions are sometimes determined by their local concentrations, which are 
dependent on intracellular localization and the presence of their interacting 
partners (Meer, 2005). Also, as the data presented were generated by a snap-
reading method, the dynamics of lipid changes in the cell cycle could not be 
recorded precisely. Hence, it is not possible to tell whether the significant lipid 
changes are a consequence or cause of cell division or both.  
While there are many other biological models, for example primary cells or 
animals, which may ideally provide a more accurate picture of the cell cycle 
regulation of lipids, cell line applications are easier to control, less expensive and 
independent on the availability of animals. In particular, common issues that 
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contribute to large data variations in animal or human subjects – like individual 
natural variations across different subjects and confounding factors like age, 
gender, health status and environmental exposures- are not major issues in cell 
culture. When cell cultures are properly controlled, variability contributed by 
external factors can be eliminated. Furthermore, cell culture work can provide a 
more constant background for comparison, and subtle metabolomic changes may 
become apparent. 
However, cell culture experiments in lipidomics are not without issues too. Cells 
are often cultured in serum containing media. Animal sera are usually undefined 
and extremely rich in lipids and cholesterol. Hence, the amount of lipids and 
cholesterol the cells are exposed in culture may vary according to the sera added 
into the culture media. Even when the specially formulated serum-free media is 
used, known but controlled amount of lipids are still present in the culture media. 
Since this work involves studying of lipids across time, cells that were cultured in 
the media for a longer period of time may take up more lipids over a longer 
cultured period than their 0
th
 hour counterpart. This issue is studied using 
untreated cells grown in culture over different time duration and in varying 
amounts of FBS. Data suggest that lipid changes in the cell cycle synchronisation 
experiments are independent of the length of time and FBS percentage they are 
cultured in. 
Differential rates of proliferation for cell lines due to growth conditions and 
culture passage number may have effects on the metabolite levels in the cells 
(Cuperlovic-Culf et al., 2010). This was overcome in this study by using cells 
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from a similar stock and seeding cells for synchronisation at the same passage 
number after thawing of the stock. In addition, the use of two different cell lines 
and drugs serves to ensure that the lipid changes observed are cell cycle related, 
not drug or cell line dependent. 
Although the proportion of each lipid class in relation to the total lipids did not 
change significantly in this study, individual species within each class did. Fatty 
acid chain length may play extremely important role in cell physiology. For 
instance, shorter or unsaturated fatty acids of phospholipids may reduce the phase 
transition temperature and change membrane curvature, thickness, and fluidity 
(Mansilla et al., 2009). However, when the lipids from different classes with the 
same degree of unsaturation were added up, there was no significant difference. 
This may indicate that the degree of unsaturation is species specific. 
PC accumulation during active cell growth, including in tumor cells, have been 
well documented in literature. A two to three fold increase in the net synthesis of 
PC species had been observed in cells progressing from metaphase to early G1. 
The newly synthesised PC were found to be mostly incorporated into the newly 
formed nuclear membranes by early telophase before chromosomal condensation 
(Henry and Hodge, 1983). Major mechanism of PC accumulation include 
enhanced choline transport and choline kinase (CK)-mediated phosphorylation 
and activation of PC-specific phospholipases (Eliyahu et al., 2007; Glunde et al., 
2004; Iorio et al., 2005). Radiolabeling experiments in BAF1.2F5 cells have 
shown a high PC turnover rate in G1 and a net increase in PC from S phase 
onwards owing to a decreased PC degradation, leading to higher levels of PC in S 
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and G2 compared to G1 (Jackowski, 1994). Another radiolabeling study in MCF7 
cells also reported increased incorporation of choline into PC in G2/M than in 
G1/S (Lin and Arthur, 2007). Similar to these studies, we found that the levels of 
diacyl PC species were higher in G2/M cells than in G1/S (Figure 3.6 and 3.9).  
In addition, unlike previous studies, our study differentiated and measured 
different PC species including ether PCs in HeLa cells. Ether lipids are lipid 
species that bear an ether-linked alkyl chain at the sn-1 position instead of the 
ester-linked fatty acid (Nagan and Zoeller, 2001). Whereas the majority of diacyl 
PC species were higher in G2/M compared to G1/S, ether PC species were lower. 
This intricate balance between diacyl PC and ether PC resulted in no significant 
change in net PC levels during the cell cycle. This phenomenon was not observed 
in MCF7 due to its lack of ether lipids (Welsh et al., 1994). 
Cell cycle changes in individual PC species were more pronounced than for other 
lipids. One possible contributing factor could be that most PCs have a relatively 
short half-life, often less than one cell generation (Bosch, 1980). For example, the 
half-life estimated for PC in cultured baby hamster kidney cells is 2-4 h, for PE is 
4-8 h, and for PI is 15 h (Gallaher et al., 1973).  While we observed fluctuations 
in individual lipid species, our study did not find overall differences in each 
phospholipid class. This may suggest that in the midst of lipid species fluctuations, 
homeostasis within a lipid class may be tightly regulated during the cell cycle. A 
recent MS study reported a cyclical pattern for multiple phospholipids that varied 
with the cell cycle, with lipid levels reaching their maximum in G2/M and 
dropping markedly after mitosis (Hague et al., 2013). It should be noted that, 
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unlike the aforementioned study that looked at absolute lipid levels per cell, our 
study investigated actual cellular lipid composition, which provides information 
on the relative abundance of each lipid species. We believe that by normalising to 
total lipids rather than to cell number, we are able to overcome the inherent issue 
of considerable cell volume variation among cultured cells, which can affect total 
lipid measures. 
Another evidence of the cells' lipid homeostasis being tightly regulated is the non- 
fluctuating levels of TAG and DAG in the cell cycle. This is in contrast to the 
belief that cells would store TAG for later utilisation during cell division, an 
energy consuming process.  
The most striking observation from this cell cycle profiling is that while most 
lipid species did not display big changes (> +/- 25%) as the cells progressed along 
the cell cycle, cholesterol esters appeared to be significantly higher (up to ~50%) 
in G2/M for both cell lines in both aphidicolin and nocodazole synchronisation 
methods. This emphasizes the potential importance cholesterol esters has in cell 
division and proliferation. As such, further studies will be conducted in attempt to 
confirm cholesterol esters' role in the cell cycle. 
 75 
 
 4. CHOLESTEROL ESTERS’ ROLE IN CELL CYCLE 
4.1 Introduction 
As cholesterol is a major regulator of membrane organisation, its cellular 
concentration must be tightly regulated. A fast way to counter excess cholesterol 
is by esterification (Chang et al., 1997). This prevents accumulation of free 
cellular cholesterol which may be subjected to conversion into oxysterols that are 
toxic to cells (Schroepfer, 2000). Unlike cellular cholesterol which can be 
obtained from external sources, intracellular cholesterol esters can only be 
synthesised. Acyl-CoA: cholesterol acyltransferase (ACAT) is an intracellular 
membrane bound enzyme that produces cholesterol esters by using cholesterol 
and long chain fatty acyl coAs as substrates (Chang et al., 1997). There are two 
main forms of ACAT in mammalian cells- ACAT1 and ACAT2. ACAT1 is 
expressed in most tissues (Chang et al., 1993; Lee et al., 1998), while ACAT2 is 
expressed only in intestines and liver (Cases et al., 1998; Chang et al., 2000; 
Oelkers et al., 1998). The esterified cholesterol produced by ACAT is stored in 
cytoplasmic lipid droplets. When needed, cholesterol esters can be released from 
the droplets in the form of cholesterol upon hydrolysis by neutral cholesterol ester 
hydrolases (Sekiya et al., 2011). 
Studies involving different models of cell proliferation and human neoplasms 
revealed that there is a consistently higher esterification of cholesterol in all 
proliferating tissues, in both normal or pathologic conditions (Pani and Dessi, 
2003). In vitro studies on leukemia cell lines with different doubling times 
demonstrated that the cell growth rate correlates with the cholesterol esterification 
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capacity of the cells as well as with the ACAT genes (Batetta et al., 1999; Dessi et 
al., 1997). It was suggested that the increased capacity to synthesis and store 
cholesterol esters may facilitate membrane biogenesis needed for cell 
proliferation as soon as the cells divide. On the other hand, cell growth rates were 
not affected by the absolute levels of de novo synthesised cholesterol or 
cholesterol uptake. It was hypothesised that cholesterol esters influence the 
balance of the growth factors in the caveolae, where signalling events take place. 
P-glycoprotein, a drug efflux pump, has been suspected of being responsible for 
regulating intracellular cholesterol esters levels, hence influencing MDR 
(multidrug resistance) phenomenon in cancer cells, which may in turn affect the 
efficacy of chemotherapy. Therefore, cells with MDR phenotype have shorter 
doubling time, accompanied by higher rates of cholesterol esterification (Pani et 
al., 2000). 
The role of cholesterol esters pathway in cell cycle control of human vascular 
smooth muscle cells (VSMC) has also been investigated. A plausible link between 
cholesterol esterification and control of cell cycle at G1/S transition was found in 
cells subjected to cholesterol esterification inhibition, either by direct (inhibition 
of ACAT by Sandoz-53-035) or indirect (inhibition of transport of cholesterol 
from plasma membrane to endoplasmic reticulum by progesterone) means. ACAT 
inhibition resulted in cells arrested in G1 phase (Batetta et al., 2003). This was 
associated with an inhibition of ERK1/2 mitogenic signalling pathway, a down-
regulation of cyclin D1, ACAT and MDR mRNA, and an up-regulation of 
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caveolin. Serum-induced VSMC proliferation was also shown to be preceded by 
an increase in ACAT expression and cholesterol esterification. 
Bemlih et al (2010) have also reported that glioblastoma growth could be 
effectively stalled by treatment of Avasimibe, a specific inhibitor of ACAT. 
Avasimibe was shown to induce apoptosis by activating caspase activities in 
glioblastoma cells (Bemlih et al., 2010). On the other hand, treatment of VSMC 
with leptin, which accelerates cholesterol esters accumulation by increasing 
ACAT activity and suppressing cholesterol efflux (Hongo et al., 2009), resulted in 
accumulation of the cells in S and G2/M (Huang et al., 2010). 
Cholesterol esterification by ACAT has also been linked to the activation of 
cholecystokinin 2 receptor (CCK2R) in tumor proliferation and invasion. When 
non tumor cells expressing CCK2R were cultured in the presence of cholesterol 
oleate, the growth rate and invasiveness of these non tumor cells matched that of 
the tumor cells. Stimulation of cholesterol esterification was mostly dependent on 
mitogenic processes involving protein kinase C (PKC)-zeta and extracellular 
signal-related MEK/ERK1/2 (Paillasse et al., 2009). 
As mentioned earlier, the cholesterol ester levels can be mediated by ACAT and 
neutral cholesterol ester hydrolases. Hence, increase in cholesterol esters could be 
due to either increase in cholesterol ester synthesis by ACAT or decrease in 
degradation by cholesterol ester hydrolase. In renal clear cell carcinoma, ACAT 
activity was higher in tumor cells, while cytosolic cholesterol ester hydrolase 
activity appeared comparable to normal kidney cells (Gebhard et al., 1987). This 
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may imply that cholesterol ester synthesis and not hydrolysis is the primary cause 
of cholesterol ester accumulation in renal cancer. 
However, all the existing information from literature like abovementioned were 
mostly derived from experiments involving drug inhibitors of ACAT or 
cholesterol esterification. Possible confounding effects of the drugs which could 
have contributed to the observation were not considered. Furthermore, cell cycle 
arrest or apoptosis observed upon drug treatment may be caused by the prolonged 
exposure to the drug toxicity, instead of the reduction in cholesterol esterification. 
From Chapter 3, it has been shown that cholesterol esters are increased 
significantly in G2/M than in G1/S (Figure 3.23 and 3.24). ACAT1 is the main 
enzyme synthesising cholesterol esters. Hence, the main focus of this chapter is to 
validate and confirm the observation, and discuss the possible importance of 




4.2 Materials and Methods 
4.2.1 Cell culture 
HeLa cells were cultured as described in Chapter 2.2. 
4.2.2 RNAi transfection of HeLa cells 
HeLa cells were transfected with ACAT1 RNAi (Silencer Select, Life 
Technologies) or negative control scrambled RNAi (hereafter referred to as 
ACAT1 knocked-down (KD) and negative control respectively) by Lipofectamine 
RNAiMAX using forward transfection, according to the manufacturer's 
instructions. Briefly, 12 hours before transfection, the cells were seeded into 6-
well plates without antibiotics such that the culture would be about 30% confluent 
at the time of transfection. 6 pmol RNAi duplex and 1 µl of Lipofectamine 
RNAiMAX were diluted in 100 µl Opti-MEM I Reduced Serum Medium without 
serum and incubated at room temperature for 15 min. The RNAi duplex-
lipofectamine RNAiMAX complexes were then added into each well containing 
cells and mixed gently by rocking the plate. The cells were incubated with the 
transfection complex for up to 60 h before cell cycle synchronisation. 
4.2.3 Fluorescence Imaging of lipid droplets 
As cholesterol esters are found mainly in the lipid droplets, HeLa cells were 
stained for lipid droplets using LD540 (gift from Christroph Thiele's lab). The 
cells were stained as reported before (Spandl et al., 2009). Briefly, HeLa cells 
were fixed with 4% paraformaldehyde overnight in 4
o
C. After which, the cells 
were washed three times with PBS, then incubated with a solution of 0.05 µg/ml 
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LD540 in PBS for 15 min, washed three times with PBS and once with water. The 
cells were then mounted in mounting medium containing DAPI stain for nuclei 
staining (Sigma). Images were captured with either a Zeiss confocal or Olympus 
fluorescent microscope. 
4.2.4 AlamarBlue assay for cell viability 
AlamarBlue assay (Life Technologies) was carried out according to 
manufacturer's instructions. ACAT1 KD or negative control cells were seeded 
into 96-well plate. Within 16 h upon plating, the alamarBlue solution was added 
into each well and incubated with the cells for 2 h. After which, the absorbances 
of mixture were read at 570 nm and 600 nm were read. The data was then 
processed by this formula:  
 
4.2.5 Analysis of kinetics of cell cycle progression 
To analyse the kinetics of cell cycle progression, it is highly desirable to 
synchronise the cells (Schori and Sedivy, 2007). Here, 5 µg/ml aphidicolin or 1.5 
mM hydroxyurea was used to synchronise the ACAT1 KD and negative control 
(O2  A1) – (O1  A2)




O1 = molar coefficient extinction (E) of oxidised alamar Blue at 570 nm = 80586
O2 = E of oxidised alamar Blue at 600 nm =117216
R1 = E of reduced alamar Blue at 570 nm = 155677
R2 = E of reduced alamar Blue at 600 nm = 14652
A1 = absorbance of test wells at 570 nm
A2 = absorbance of test wells at 600 nm
N1 = absorbance of negative control wells (media and alamar Blue only) at 570 nm
N2 = absorbance of negative control wells at 600 nm
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cells at G1/S as previously described in Chapter 2.3. The cells were then allowed 
to progress into the cell cycle. The cells were also synchronised at G2/M with 
microtubule disruptor 100 ng/ml nocodazole as mentioned in Chapter 2.3, and 
then allowed to progress through the cell cycle. Cells were collected at specific 
time points, fixed with ethanol, and stained with propidium iodide before being 
subjected to FACS analysis as described in Chapter 2.4. Figure 4.1 depicts a 
summarised timeline of the whole process from siRNA transfection to sample 
collection for further analysis. 
 
Figure 4.1 Timeline to summarise the process from ACAT1 knockdown to 
cell cycle synchronisation and cell collection. 
 
4.2.6 Analysis of ACAT1 and cyclin levels using western blot 
To confirm that the ACAT1 knock-down system is working and there is a 
decrease in ACAT1 expression on the protein level, western blots on ACAT1 
(Santa Cruz) was carried out as described in Chapter 2.5.  
To complement the flow cytometric data, protein levels of cyclins were analysed 
using western blots on the samples synchronised by aphidicolin as mentioned in 
Chapter 2.5. Proteins speculated to play a role in the control of cell cycle, such as 
Seeding of Passage 4 HeLa cells
0th h
12th h
siRNA transfection 72th h
Remove siRNA, rinse cells 
with PBS, treat cells with 
aphidicolin/nocodazole/ 
hydroxyurea 84th h
96th hRelease cells from 
nocodazole
synchronisation and 
collect at specific 
timepoints for 24h








p53 (antibody from BD Biosciences), caveolin-1 (BD Biosciences) and p21 
(Santa Cruz), were also probed. 
4.2.6 MS analysis of phospholipids, sphingolipids and cholesterol in ACAT1 
and negative control cells 
Lipids were extracted by Bligh and Dyer's method, and then subjected to LC-MS 
MRM analysis, as mentioned in Chapter 2.6. 
4.2.7 Time-lapse Imaging of ACAT1 KD and negative control cells 
HeLa cells were seeded into 6-well plates, transfected with RNAi, then 
synchronised with aphidicolin for 24 h. Upon release from aphidicolin 
synchronisation, the cells were imaged live under 10 x magnification at 10-minute 
interval using Cell-IQ continuous live cell imaging and analysis platform (CM 
Technologies) over a period of 48 h. The phase contrast images were then 
processed automatically to identify and count dividing cells (rounded) and non-





4.3.1 Fluorescent imaging of lipid droplets at different cell cycle phases and 
MS analysis of individual cholesterol ester species 
As mentioned in Chapter 3, the levels of total cholesterol esters were higher in 
G2/M cells compared to G1 cells. As cholesterol esters are mainly found in lipid 
droplets within the cell, the cells were stained for lipid droplets using LD540. 
Indeed, number and size of lipid droplets increased in G2/M cells for both 
aphidicolin and nocodazole synchronisation methods (Figure 4.2). This provided 
convincing evidence that the increase of cholesterol esters in G2/M using either 
method was due to cell cycle influence and not because of drug effects. It also 
showed that the increase in cholesterol ester we observed in the cell cycle mainly 





Figure 4.2 Fluorescent microscope images of cells in different stages of the 
cell cycle. Blue represents DAPI stain of the nuclei, red represents LD540 stain of 
the lipid droplets. A and D show cells in G2/M phase, and G1 cells in B and C. E 
and F are graphical representations of the mean fluorescent intensities of lipid 
droplets in nocodazole and aphidicolin synchronised cells respectively. The 
fluorescent intensities were measureed using ImageJ. n=3, *p<0.05. 
 
  
A- 0h after release from Noco
(G2/M)
B- 8h after release from Noco
(G1)
C- 0h after release from Aph
(G1/S)


























































































 So far, no work has been published about the levels of individual cholesterol 
ester species in cell cycle. Here, levels of individual cholesterol ester were 
analysed. Figure 4.3 illustrates the fold change of each cholesterol ester in G2/M 
as compared to G1/S in aphidicolin synchronised HeLa cells. All cholesterol 
esters were significantly higher in G2/M than in G1/S cells, with at least 1.47 fold 
change increase in each species. 
 
Figure 4.3 Fold change of each cholesterol ester species in G2/M as compared 












































4.3.2 Determination of ACAT1 protein expression, cell viability and lipid 
profile of ACAT1 KD cells 
Fluorescent imaging showed a significant decrease in LD540 staining in ACAT1 
KD cells, indicating that lipid droplets had become smaller in size or numbers due 
to the decrease in cholesterol esters storage (Figure 4.4A and B).   
Expression of ACAT1 protein was also lower in ACAT1 KD cells as compared to 
negative control cells which were mock-transfected with scrambled siRNA 
(Figure 4.4C).  
 
Figure 4.4 Effects of ACAT1 KD by RNAi transfection in HeLa cells. (A) 
Fluorescent images of lipid droplets (red with LD540) in cells under 40x 
magnification in both ACAT1 KD and negative control cells. Image areas boxed 
in yellow were enlarged in the right most panel. (B) Bar graph showing the mean 
fluorescent intensity of LD540 in ACAT1 KD and negative control cells. Mean 
fluorescent intensity was quantified by ImageJ. n=3, *p<0.05. (C) Protein 
expression of ACAT1 in ACAT1 KD and negative control cells. GAPDH was 



























































AlamarBlue assay, an indicator of cell metabolism, was carried out to determine 
whether the knock-down of ACAT affects cell viabilty. AlamarBlue is blue and 
non-fluorescent in its oxidised state, and is reduced to fluorescent pink by cell 
activity. The reduction of alamarBlue in the growth media is directly proportional 
to the quantity of living cells (O'Brien et al., 2000). Figure 4.5 illustrates that 
ACAT1 KD did not affect cell viability. 
 
Figure 4.5 Fold change in the percentage reduction of alamarBlue at 24 h 


































































ACAT1 KD Negative Control
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To determine if there was any other perturbation to the lipid metabolism in 
ACAT1 knockdown cells, mass spectrometry analysis of lipids was also carried 
out. There were no significant differences in the phospholipid and sphingolipid 
profiles between the ACAT1 KD and negative control cells (Figure 4.6). However, 
cholesterol level was significantly higher in ACAT1 KD cells compared to 
negative control. This could be attributed to the lack of ACAT1 enzyme to 
convert cholesterol to cholesterol esters. As expected, cholesterol esters level was 
significantly lower in ACAT1 KD cells. TAG and DAG were also significantly 
lower in ACAT1 KD cells, probably due to the diminished lipid droplet size with 
less cholesterol esters synthesis and storage. 
 
Figure 4.6 Lipid profile of ACAT1 KD and negative control cells. Error bars 



















































4.3.3 Cell cycle progression of ACAT1 KD cells upon release from 
aphidicolin synchronisation 
To determine the cell cycle phase at which cholesterol esters are essential, the cell 
cycle progress of ACAT1 KD cells was tracked upon their release from G1/S 
synchronisation by aphidicolin. FACS analysis showed that ACAT1 KD cells 
progressed to S and G2/M phase at the same rate as negative control cells (Figure 
4.7). However, at 16 h, most of the ACAT1 KD cells maintained a DNA content 
similar to that of G2/M, while negative control cells had entered the next G1 





Figure 4.7 Cell cycle kinetics of ACAT1 KD and negative control cells which 
were released from G1/S synchronisation by aphidicolin. ACAT1 KD and 
negative control cells were arrested at G1/S by aphidicolin synchronisation, 
released and collected at several time points for FACS analysis. (A) Bar graph of 
cell cycle progression of ACAT1 KD cells. (B) Bar graph of cell cycle 






























































To confirm the observed G2/M arrest of ACAT1 KD cells compared to negative 
control cells, we assessed the cyclin protein levels in both ACAT1 KD and 
negative control cells (Figure 4.8A and C). The results suggest that there was a 
delay in peak expression of G2/M cyclins A and B in ACAT1 KD cells. Unlike 
negative control cells, levels of cyclin A and B remained high after 10 h in 
ACAT1 KD cells. G1/S cyclins D and E, on the other hand, peaked earlier in 
negative control cells than in ACAT1 KD cells. These fluctuations in cyclins 
agree with the kinetics study. 
One of the factors that affect cyclin B levels and G2/M progression is the tumor 
suppressor protein p53. p53 has been reported to control mitotic initiation by 
regulating cyclin B levels and attenuating cyclin B promoter activity (Innocente et 
al., 1999). Both p53 and p21 have also been shown to be essential for long term 
G2 arrest after DNA damage (Bunz et al., 1998). Since p53 plays an important 
role in cell cycle regulation, its levels were also analysed. Levels of p53 were 
found to be higher in ACAT1 KD cells compared to negative control cells from 4 
h onwards. Caveolin-1, a primary component of caveolae membranes, has been 
reported to mediate cell cycle progression through a p53/p21 pathway (Galbiati et 
al., 2001). In our present study, caveolin-1 levels were consistently lower in 
ACAT1 KD cells (Figure 4.8A and C). Levels of p21 increased over time in the 
ACAT1 KD cells while levels of the p53-regulated protein 14-3-3 sigma were 
consistently higher in ACAT1 KD than in negative control cells (Figure 4.8B and 
C), suggesting that they may be involved in the G2/M arrest induced by 




Figure 4.8 Western blots for ACAT1 KD and negative control cells released 
from aphidicolin synchronisation. Western blot was performed after HeLa cells 
were released from aphidicolin synchronisation. (A) Cyclins B, A, D and E, p53, 
caveolin-1 were probed. GAPDH was used as a loading control. (B) p21 and 14-
3-3 sigma were probed. GAPDH was used as a loading control. (C) Densitometric 
analysis of the respective protein expression against that of GAPDH for 10, 16 
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4.3.4 Cell cycle progression of ACAT1 KD cells upon release from 
hydroxyurea synchronisation 
To confirm that the G2/M arrest phenomenon in ACAT1 KD cells is not unique to 
aphidicolin synchronised cells, another cell cycle synchroniser, hydroxyurea (HU), 
was used. HU acts specifically on the cell cycle by inhibiting ribonucleoside 
diphosphate reductase, hence preventing the conversion of ribonucleotides to 
deoxyribonucleotides, and ultimately hindering de novo DNA synthesis (Madaan 
et al., 2011). Flow cytometry of cells released from HU G1/S synchronisation also 
revealed similar observations like that of aphidicolin (Figure 4.9). ACAT1 KD 
cells progressed to S and G2/M phase normally, like negative control. However, 
after 16 h upon release from HU, ACAT1 KD cells remained in G2/M, while 
negative controls had already progressed into the next G1 phase. This observation 
confirmed that accumulation of cholesterol esters is not limited to aphidicolin 
synchronised cells and cholesterol esterification is essential for the progress of 




Figure 4.9 Cell cycle kinetics of ACAT1 KD and negative control cells which 
were released from G1/S synchronisation by hydroxyurea. (A) Bar graph of 
cell cycle progression of ACAT1 KD cells. (B) Bar graph of cell cycle 





























































4.3.5 Cell cycle progression of ACAT1 KD cells upon release from 
nocodazole synchronisation 
To further establish the importance of cholesterol esters in G2/M progression, we 
examined the cell cycle kinetics of ACAT1 KD and negative control cells 
released from nocodazole synchronisation. FACS analysis revealed that a greater 
proportion of ACAT1 KD cells were synchronised at G2/M at start point (0 h) 
compared to negative control. However, both ACAT1 KD and negative control 
cells eventually reached similar proportions of G2/M and G1 cells by the second 
hour. At 4 h post-release from nocodazole, a higher proportion of ACAT1 KD 
cells remained in G2/M compared with negative control (Figure 4.10A and B). 
The ratio of G2/M to G1 cells is higher in ACAT1 KD than in negative control 
(Figure 4.10C), indicating that cholesterol esters are indeed crucial for the G2/M 




Figure 4.10 Cell cycle kinetics of ACAT1 KD and negative control cells which 
were released from G2/M synchronisation by nocodazole. (A) Bar graph of 
cell cycle progression of ACAT1 KD cells. B) Bar graph of cell cycle progression 
of negative control cells. (C) Ratio of G2/M to G1 cells in negative control and 

























































































4.3.6 Time lapse observation of cell division in ACAT1 KD and negative 
control cells 
In order to find out whether the higher percentage of ACAT1 KD cells in G2/M 
was due to more active and rapid cell division or cells being arrested at the 
division phase, label-free time lapse phase contrast microscopy was carried out to 
observe the cell division. It indicated that a higher proportion of ACAT1 KD cells 
were in the state of mitosis at all the time points observed (Figure 4.11A). In fact, 
the second cycle reached division stage later in ACAT1 KD cells. Observation of 
individual cells for 12-24 h post release from aphidicolin revealed that ACAT1 
KD cells took a longer average time to complete one division compared to the 
negative control (Figure 4.11B). One division is measured from the time the cell 
rounds up in mitosis to when it divides into two daughter cells. Examples of such 





Figure 4.11 Time lapse observation of cell division after release from 
aphidicolin synchronisation. (A) Graph representing the proportion of dividing 
cells to non-dividing cells for ACAT1 KD and negative control over a period of 
48 h. (B) Scatter plot showing the time taken for individual cells to complete 
mitosis. Individual cells were manually tracked over several frames, as the cells 
progressed from rounded detached morphology to divided reattached state. 
*p<0.05, n=60. (C) Time lapse images of cell division in ACAT1 KD cells. Cell 
(arrowed) was tracked from before it underwent mitotic roundup to the time it 
rounded up and then divided into two. The cell took 99 min to complete mitosis. 
(D) Time lapse images of cell division in negative control cells. Two cells 
(arrowed) were tracked from the time they rounded up (8 min) to the time they 
divided into two, one at 38 min and another at 53 min. Both cells took 30 min and 
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To eliminate any speculation that the observations made may be due to 
aphidicolin effects on the cell cycle, similar analyses were carried out for 
unsynchronised ACAT1 KD and negative control cells. The same observation 
was made in unsynchronised ACAT1 and negative control cells (Figure 4.12), 
where the time required for ACAT1 KD cells to divide was significantly longer 
than negative control cells. This implies that deficiency in cholesterol esters slows 





Figure 4.12 Analysis of cell division in unsynchronised ACAT1 and negative 
control cells. (A) Graph representing the proportion of dividing to non-dividing 
cells over a period of 48 h. (B) Scatter plot showing the time taken for individual 
cells to complete mitosis. Cells were tracked from the point where they rounded 















































In fact, some ACAT1 KD cells went into apoptosis after being stuck in mitosis for 
a prolonged period of time (Figure 4.13). This observation correlates well with the 
increase in p53 protein expression in ACAT1 KD cells as seen in Figure 4.8A. 
 
Figure 4.13 Time lapse images of ACAT1 KD cells arrested in mitosis. After 
prolonged rounding up of the cells, the cells (arrowed) started exhibiting signs of 
apoptosis, including blebbing phenotype (marked *). 
 
  
*Apoptotic blebbing after prolonged mitotic arrest
0 min 8 min 1 h 46 min
5 h 41 min 8 h 19 min
17 h 38 min





 4.4 Discussion 
From Chapter 3.5, we observed a higher level of cholesterol esters in G2/M cells 
compared to G1/S, and no change in DAG/TAG. Cholesterol esters, being more 
hydrophobic, occupy the core of cytosolic lipid droplets together with TAG, with 
varying ratios depending on cell types (Tauchi-Sato et al., 2002). It was 
postulated that the number or size of lipid droplets should decrease as the storage 
lipids are utilised as material for expanding membranes in the growing cell 
preparing to divide. In budding yeast, for instance, neutral lipid breakdown was 
related to the cell cycle (Kurat et al., 2009).  A contrasting theory argues that the 
number of lipid droplets should increase so that daughter cells would have equal 
droplet numbers as the parent cell. This is supported by studies in fission yeast 
where the number of lipid droplets increased during G2 phase through de novo 
formation and fission (Long et al., 2012). In our present study, it was also shown 
that cells have more or larger lipid droplets in G2/M, based on the higher intensity 
of LD540 stain (Figure 4.2). Linking this up with lipid analysis, it would imply 
that cholesterol esters make up a bigger proportion in lipid droplets and have a 
role in cell cycle regulation. The increase in number or size of lipid droplets may 
be essential as they have been associated with control of histone levels and 
promotion of mitotic fidelity like in syncytial embryos in Drosophila. It was 
proposed that lipid droplets serve as a reservoir for histones for chromatin 
assembly by shielding histones from premature degradation, thereby limiting the 
pool of free, potentially toxic histones (Welte et al., 2012). Therefore, the increase 
in lipid droplets in G2/M as shown in this study may be due to the need to 
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sequester excess histones and provide a ready supply of histones when needed in 
the next cell cycle. 
In this study, cell cycle kinetics using different forms of synchronisation showed 
that ACAT1 dependent cholesterol esterification is necessary for timely G2/M 
progression. Absence of cholesterol esters led to prolonged periods of G2/M as 
observed in aphidicolin, hydroxyurea and nocodazole synchronisation. Western 
blot of cyclin B showed a delayed increase in cyclin B in ACAT1 KD cells 
(Figure 4.8A). Cyclin B protein expression also persisted longer in ACAT1 KD 
cells than in negative control cells. Level of cyclin B has been reported to be a 
controlling factor in the length of G2 delay (Theron and Bohm, 1998) and is 
critical for the proper timing of entry into mitosis (Ito, 2000). In human cervical 
carcinoma, cyclin B expression has also been associated with tumor invasiveness. 
Belated cyclin B availability and the resultant G2 delay have been linked to DNA 
damage in irradiated HeLa cells (Kao et al., 1997). Furthermore, DNA damage 
can result in metaphase-anaphase transition delay and this is accompanied by 
Cyclin A stabilisation (den Elzen and Pines, 2001; Su and Jaklevic, 2001). 
Therefore, the prolonged high expression of cyclin A in ACAT1 KD cells may 
indicate that the cells were in need for DNA repair before entering mitosis, 
accounting for the delayed cyclin B accumulation and a longer G2/M phase. 
There has been association of proteins with lipid esters in lipid droplets via 
hydrophobic interactions, thus suggesting that lipid droplets act as a temporary 
protein storage site (Cermelli et al., 2006). Hence, it could be hypothesised that 
ACAT1 KD-induced G2 delay could be due to the decrease in cholesterol esters 
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in the lipid droplets which are essential for docking proteins important for cell 
cycle progression.  
Western blot analysis also revealed an earlier expression in cyclin D and E in 
negative control cells from 16 h onwards (Figure 4.8A). This is in accordance to 
the observation that the negative control cells enter G1 of the next cell cycle phase 
earlier than the ACAT1 KD cells.  
In fact, as cells were followed from the point of mitotic roundup to the time when 
they divided into two during the first cell cycle after release from aphidicolin, it 
was observed that ACAT1 KD cells were stuck in the rounded stage about twice 
longer than the negative control cells.  
Some may argue that the observations made in ACAT1 KD and negative control 
aphidicolin-synchronised cells were unique to the case of aphidicolin 
synchronisation. This concern can be addressed by similar observations made in 
ACAT1 KD and negative control cells synchronised by HU. ACAT1 KD cells 
released from HU were also stuck at G2/M, according to FACS data (Figure 4.9). 
When synchronised at G2/M by nocodazole, ACAT1 KD cells also exited M 
phase later than negative control cells (Figure 4.10). In time lapse experiments, 
unsynchronised ACAT1 KD cells also had a higher proportion of cells in mitotic 
roundup state, and after tracking individual cells for a period of time, it was also 
observed that ACAT1 KD cells took a significantly longer time to complete 
mitosis, in the absence of any drug perturbations (Figure 4.12). 
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In some cases, mitotic roundup cells underwent apoptosis after failing to divide or 
returned to their attachment state without dividing. In fact, ACAT1 KD cells had 
accumulated a higher amount of p53 at the later time points after release from G1 
block, when most of the cells were arrested in G2/M (Figure 4.8A). There are 
many possible roles that p53 may play in this observation. p53 is known to 
control the G2 checkpoint by suppressing intracellular cyclin B protein levels and 
attenuating cyclin B promoter activity (Innocente et al., 1999). In addition, p53 
may anchor cyclin B in the cytoplasm, thereby preventing its nuclear entry to 
initiate mitosis (Taylor and Stark, 2001). Hence, despite the increase in cyclin B 
that we observed in ACAT1 KD cells, a huge proportion of cells did not progress 
through mitosis on time, suggesting that cyclin B may not appropriately localised 
to initiate mitosis. Alternatively, the aberrantly high levels of p53 may lead to an 
increase in the level of p21 which inhibits Cdc2/cyclin B (Taylor and Stark, 
2001). Induction of p21 has been reported to arrest HeLa cells in G2 phase 
(Taylor and Stark, 2001). Levels of 14-3-3 sigma, another player downstream of 
p53 which also causes cell cycle arrest, were constantly higher in ACAT1 KD 
cells, indicating that 14-3-3 sigma may also be involved in the cell cycle arrest in 
ACAT1 KD cells. Further experiments such as quantitative proteomics and 
functional assays need to be carried out to confirm these observations. 
Caveolae are distinct, highly regulated lipid and protein domains of the plasma 
membranes, where several key cellular processes take place. Caveolin, an 
essential component of caveolae, is crucial in regulating intracellular homeostasis 
of lipids, cell activation and cell proliferation (Fernández et al., 2006), and it may 
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be linked to lipid droplet functions (Cohen et al., 2004). In this study, levels of 
caveolin-1 were lower in ACAT1 KD cells than in negative control (Figure 4.8A). 
Caveolin-1 is supposed to play a critical role in sensing DNA damage and 
regulating important steps involved in maintaining genomic integrity (Zhu et al., 
2010). The lower levels of caveolin in ACAT1 KD cells may indicate that the 
cells are unable to repair their replicated genome and that this delayed exit from 
G2/M. In addition, a study by Fernández et al (2006) revealed the importance of 
caveolin-1 in liver regeneration (Fernández et al., 2006). Hepatocytes in caveolin 
knocked-out mice showed significantly less lipid droplet accumulation and did 
not advance through the cell cycle. The authors also drew a metabolic relationship 
between caveolin and lipid droplets with S phase of the cell cycle. This again 
supports the hypothesis that the observed decrease in cholesterol ester in lipid 
droplets may result in a disturbed S phase, leading to prolonged G2/M. 
Mitosis is a very vulnerable period of the cell cycle. Compared to cells in 
interphase, mitotic cells are more easily killed or prevented from proliferating in 
the presence of anti-proliferating agents like irradiation, heat shock or chemicals 
(Rieder and Maiato, 2004). As gene transcription is halted in mitosis, extended 
time in cell division may cause reduced viability due to the cells' inability to carry 
out its vital functions. Furthermore, when G2/M arrested cells exit a prolonged 
mitosis, the daughter cells produced often contain altered genomes. Such cells 
often cannot divide or undergo apoptosis (Rieder and Maiato, 2004).  In fact, cells 
that are easily arrested in mitosis are proven more susceptible to cancer treatment. 
For instance, Taxol acts directly on spindle microtubles, resulting in mitotic 
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arrest, the main attribute to its cytotoxicity (Jordan and Wilson, 2004; Mollinedo 
and Gajate, 2003). Even drugs which do not interfere with the mechanics of 
mitosis may also exert their therapeutic effectiveness at G2/M. For example, 
topoisomerase inhibitors, which work mainly by damaging DNA, also affect 
mitosis. Many tumor cells which have dysfunctional G2 checkpoint often get 
entrapped when treated with such drugs as they are arrested in mitosis with 
broken DNA. This mitotic catastrophe has lethal effects on the cells  (Castedo et 
al., 2004).  
In a nutshell, cholesterol esterification and storing cholesterol esters in lipid 
droplets are important processes in cell division. Cholesterol released from 
cholesterol esters may be used for cell membrane formation immediately after 
mitosis. Since the cells would have almost grown to its maximum in G2/M, there 
is lower rate of cell membrane biogenesis, resulting in more unused cholesterol 
being stored as cholesterol esters. This store serves as a ready source for 
membrane biogenesis as soon as the cells divide. Although most of the existing 
literature points to the relationship between cholesterol ester deficiency and G1/S 
arrest (Batetta et al., 2003; Bemlih et al., 2010), we saw a prolonged G2/M phase. 
It is probable that the apparent contradiction in results is due to the fact that the 
G1/S arrest observed in other studies was pre-empted by an extended G2/M 
phase. Since mitotic cells are more vulnerable, it can be postulated that cancer 
cells could be made more sensitive to chemotherapeutic drugs by inhibiting 




 5. BREAST CANCER LIPIDOMICS 
5.1 Introduction 
From Chapter 3, we have observed that the cell cycle is a highly regulated process 
with respect to lipid metabolism. In Chapter 4, the upset of cholesterol esters 
balance led to G2/M arrest, further indicating their importance in cell cycle. 
Dysregulation of the cell cycle can have two extreme effects: cell death or 
uncontrolled cell growth, eg. cancer. Cancer is often regarded as a disease of the 
cell cycle (Park and Lee, 2003). In this chapter, using human breast cancer as a 
model, we shall attempt to investigate the lipid profiles of normal and cancerous 
tissues, and relate these to our earlier findings on lipid changes in cell cycle. 
Breast cancer is one of the most common cancer in women. Despite many 
advances in screening, surveillance, and intervention, many women still succumb 
to the progressive disease. The etiology of breast cancer is multifactorial (Key et 
al., 2001). However, the exact cause of breast cancer has yet been determined, as 
the disease presumably represents a complex interlink of genetics and 
environmental factors (Shields and Harris, 2000). Breast cancer results from 
multistep carcinogenesis and the malignant transformation process is associated 
with profound metabolic disturbances. Hence, tailoring clinical approaches for 
different patients is essential for better control and treatment of the disease. 
Metabolomics, including lipidomics, may play a role in the search for customised 
treatment for every patient.  
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One of the early events in carcinogenesis is the activation of lipid metabolism. 
Fatty acid synthase (FAS) has been associated with the "lipogenic phenotype in 
cancer pathogenesis" (Menendez and Lupu, 2007).  Studies on the lipid 
metabolism of cancer cells have mainly focused on lipid-related genes and 
proteins, most of which are shown to be involved in cancer growth and 
progression. Expression of fatty acid synthesising enzymes, particularly FAS and 
human acetyl-coA carboxylase (ACC), are often increased in the early 
development stages of the human breast carcinoma. This suggests the activation 
of a complex multigene mechanism for fatty acid synthesis in tumorigenesis 
(Milgraum et al., 1997). In fact, expression of FAS has been widely associated 
with cancer aggressiveness, and is related to growth, survival and poor prognosis 
in many cancer types, including lung, prostate and breast (Milgraum et al., 1997; 
Swinnen et al., 2002; Visca et al., 2004). This may indicate that fatty acid 
synthesis is involved actively in the maintenance of the high energy expenditure 
of fast growing tumors, thus enhancing the malignant phenotype. A 
transcriptional profiling of two isogenic models of transformation reveals a gene 
signature linking cancer with lipid metabolism and other diseases associated with 
lipid signalling (Hirsch et al., 2010). For instance, some of the lipid regulating 
genes that were found to be increased in cancer transformation were OLR1 
(oxidised LDL receptor 1), SREBP-1, SNAP23, and VAMP4. Depletion of OLR1 
inhibited several characteristics of cancer including morphological transformation, 
cell motility like migration and invasion, and cell growth in three different cell 
lines (MCF7, HepG2- hepatocellular carcinoma, and HeLa). Lipid metabolism 
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genes OLR1, GLRX, and SNAP23 were also reported to be overexpressed in late 
stages of breast and prostate cancer tissues, and their high expression levels are 
associated with greater aggressiveness and metastatic potential (Hirsch et al., 
2010).  
Fatty acid analysis by GC-MS also revealed significant differences in fatty acid 
compositions between invasive breast cancer and reference tissues (Chajès et al., 
1995). Higher levels of palmitic, palmitoleic and arachidonic acids, and low levels 
of linoleic acid, were found in membrane phospholipids of breast tumors with 
poor histoprognostic grade. 
Another study on the composition and turnover of radioactive phospholipids and 
neutral lipids in human breast cancer and reference tissues showed that the former 
had lower TAG but higher phospholipid contents compared to the latter (Sakai et 
al., 1992). In fact, TAG turnover rates were higher in cancer tissues, while 
phospholipid turnover rates appeared similar in both tissue types. In cancer tissues, 
the total n-3 ('3' designating the first position of the double bond numbered from 
the methyl terminus) and n-6 fatty acid contents in TAG were lower than those in 
phospholipids, suggesting that the metabolism of these fatty acids from TAG to 
phospholipids in more actively growing cells. The PC/PE ratio was also higher in 
cancer than in reference tissues, indicating the differences in the metabolism of 
these phospholipids in tissues of different growth rates, eg. conversion of PE to 
PC via methylation.   
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When metabolic changes in breast cancer tissue were visualised using 1H-NMR 
spectroscopy, several lipid metabolites were observed to have elevated levels 
associated with high malignancy (Beckonert et al., 2003). PE, fatty acids, 
cholesterol and cholesterol esters were increased in tumor tissue. In particular, 
sphingomyelin  species were increased predominantly in grade 3 tumors.  These 
alterations again reflect the increasing turnover in lipid metabolism in relation to 
proliferation and malignant transformation. 
Metabolites of lipids are also found to be altered in breast tumors. For instance, 
there have been reports on marked metabolic alterations of choline and choline 
containing compounds in breast (Oakman et al., 2011) and colorectal (Ong et al., 
2010) cancers. These higher levels correlate with induced membrane transport of 
choline, upregulation of phospholipases and choline kinase activity (Rachel Katz-
Brull et al., 2002). Increase in phosphocholine and decrease in PC are strongly 
correlated with the rate of cellular turnover and tumor growth (Ting et al., 1996). 
Apart from acting as a substrate for PC synthesis, choline also plays other roles to 
stimulate cell growth. For example, choline has been associated with signal 
transduction by acting as second messengers for Ras-Raf-MAPK cascade and 
protein kinase C pathway. Some of the receptors downstream of Ras/Raf are 
tyrosine kinases (Cuadrado et al., 1993), whose expression may also be amplified 
by choline (Ratnam and Kent, 1995). Particularly, erb-B1/epidermal growth factor 
receptor (EGFR), erb-B2/human epidermal growth factor receptor 2 (Her2) and 
erb-B3 play a critical role in carcinogenesis and phenotypic characteristics of 
breast cancer subtypes.  
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Many isolated attempts have been carried out to decipher lipid patterns in cancer, 
but little was done to link these changes to cell physiology and function, including 
the main cause of cancer- the dysregulation of cell cycle. Here, the main objective 
is to compare the lipid profile of normal human breast and tumor tissue, and 




5.2 Materials and Methods 
5.2.1 Breast cancer samples 
Breast cancer tissues were provided by the NUH-NUS Tissue Repository. The 
tissue samples were collected and snap frozen in liquid nitrogen within the 
shortest possible time after excision in the operation theater and analysed by a 
service pathologist at National University Hospital, by the NUH-NUS Tissue 
Repository. As controls, matched normal breast tissue obtained at the time of 
tumor surgery but not containing tumor cells was used. In total, 10 pairs of 
samples were profiled. All patients had breast tumors of invasive or infiltrating 
properties, but of different stages or grades. None of the patients had prior 
medications which may interfere with lipid metabolism. 
5.2.2 Lipid analysis 
Tissue samples were homogenised and lipids were extracted as described in 
Chapter 2. Lipids, including phospholipids, sphingolipids and sterol derivatives 
were analysed using mass spectrometry as described earlier.  
5.2.3 Statistical analysis 
Statistical analysis was conducted using SPSS. The significance of the differences 
between the tumor and control were determined using Mann Whitney U test, as 





5.3.1 Phospholipid and sphingolipid profiles of breast tumor vs control 
 
Due to the small sample size (n=10), the samples were not subdivided into more 
defined groups, like estrogen receptor status, ethnicity, stages and grades. Hence, 
the data presented is a control-tumor comparison.  
The overview of relative levels of phospholipids and sphingolipids in control and 
breast tumor samples is represented as a heatmap in Figure 5.1A. When the sum 
of each lipid class was calculated, levels of PG and PI were significantly higher in 
tumor tissues when compared to control (Figure 5.1B). Lipid species which were 
significantly different between the two groups of tissues were further represented 
in bar graphs in Figure 5.2. Certain trends could be observed. For instance, PCs 
which were significantly lower in tumor tissues contained polyunsaturated fatty 
acids, while PCs which were significantly higher in tumor cells had saturated or 
monounsaturated fatty acids. This implies the importance of fatty acid degree of 
unsaturation in cancer progression. Lower levels of lyso-PE and higher levels of 
diacyl PE were detected in tumor tissues. Specific GluCer and SM species 
showed opposite trends, with the former being consistently higher in tumor tissues. 
This may imply a preference of conversion of Cer to GluCer instead of SM. 
Majority of PI and PS species, which showed significant differences, were higher 
in tumor tissues. Two PG species appeared to be significantly higher in tumor, 




Figure 5.1 Overall phospholipid and sphingolipid changes in control versus 
tumor breast tissue samples. (A) Heatmap representing the lipid profiles of 
number-matched control and tumor breast tissue. Values of each lipid species 
were normalised to the average of each lipid species across all samples and taken 
to Log10. (B) Bar chart representing the average of fold changes in the sum of 
each lipid class in tumor samples against control tissue samples. Error bars 





























































































































































































































































Figure 5.2 Bar charts showing lipid species that were significantly different in tumor samples as compared to 
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The data were further analysed for the differences in the carbon chain number and 
total degree of unsaturation in phospholipids between the tumor and control 
tissues (Figure 5.3). It was observed that lipids with odd chains (33 and 35 
carbons) were lower in tumor tissues. This could be due to the decreasing trend in 
most of the odd chain PCs as shown in Figure 5.2. On the other hand, there is a 
significant increase in long chain lipids (carbon chain length of 40) (Figure 5.3). 
In terms of fatty acid degree of unsaturation, there were no major differences 
between tumor and control tissues, except for monounsaturated lipids, which were 
significantly higher in tumor tissues. This is also reflected in Figure 5.2, where PC 





Figure 5.3 Bar charts representing the fold change in the total carbon chain 
length (A) and degree of fatty acid unsaturation (B). Error bars represent 





























































































5.3.2 Sterol profile of breast tumor versus control 
 
Cholesterol and its derivatives were also measured. Levels of cholesterol, 
squalene and cholesterol esters were significantly different between the tumor and 
normal tissues (p<0.05). Tumor tissues showed lower levels of cholesterol and 
squalene, and higher levels of cholesterol esters (Figure 5.4) 
 
Figure 5.4 Fold change of sterol and its derivatives in control and tumor 
















































 5.4 Discussion 
In this study, the total PI level was noted to be significantly higher in tumors 
compared to control tissues (Figure 5.1B). This may be due to PI being involved 
in the inositol phosphate metabolism. For example, phosphatidylinositol-3-kinase 
PI3K, produces important second messengers like PI(3,4,5)P3, thereby regulating 
various cellular processes like proliferation, growth, apoptosis and cytoskeletal 
arrangement (Vivanco and Sawyers, 2002). In fact, PI3K overactivation has been 
reported in breast cancer (Sun et al., 2001). 
The total levels of PG are also higher in tumor tissues compared to control (Figure 
5.1B). This observation is also confirmed in cancerous cervical tissue, where PG 
levels are five folds higher than that in normal cervical tissue (Preetha et al., 
2005). Cardiolipin (CL) is a phospholipid found exclusively in the inner 
mitochondrial membrane and is involved in mitochondrial functionality and 
membrane integrity. CL's complexity results from synthesis and remodelling, and 
PG is a precursor of CL (Daum and Vance, 1997; Joshi et al., 2009; 
Mileykovskaya et al., 2005). The hypothesis that cancers are originated from 
irreversible damage of mitochondrial respiration was first supported by Otto 
Warburg (Warburg et al., 1924). Abnormalities in CL can lead to impairment of 
mitochondrial function and bioenergetics (Mileykovskaya et al., 2005). It is 
reported that there are major CL abnormalities in terms of content or composition 
in all tumors due to defects in CL synthesis and remodelling, and this is usually 
accompanied by abundance of immature CL species (Kiebish et al., 2008). The 
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higher levels of PG in tumor tissues may be due to the inability of the tumor cells 
to convert PG to CL effectively. 
A significant increase in monounsaturated lipids was also observed. One of the 
key regulators of monounsaturated fatty acid synthesis is stearoyl-coA desaturase 
(SCD), which catalyses the introduction of the first double bond in saturated fatty 
acids (Paton and Ntambi, 2009). In vitro studies have suggested a causal 
relationship between monounsaturated fatty acid synthesis and several biological 
properties of the cancer phenotype. SCD expression is higher in several human 
cancers, chemically induced tumors and oncogene-transformed cells (Kumar-
Sinha et al., 2003; Scaglia et al., 2005; Yahagi et al., 2005). Furthermore, 
suppression of SCD expression decreases in vitro cancer cell proliferation and 
invasiveness, with impaired tumor formation and growth (Morgan-Lappe et al., 
2007; Scaglia et al., 2009; Scaglia and Igal, 2005; Scaglia and Igal, 2008). SCD-1 
was identified from a siRNA library as a candidate which would diminish human 
cancer cell survival when suppressed (Morgan-Lappe et al., 2007). The decrease 
in ratio of monounsaturated fatty acids to saturated fatty acids in lung tumor cells 
was reported to cause a decrease in cell proliferation and anchorage-independent 
growth, both of which were characteristics of tumor cells (Scaglia and Igal, 2008). 
In fact, Chajès et al suggested that fatty acid desaturation index of blood lipids, as 
a biomarker of hepatic stearoyl-coA desaturase expression, is a predictive factor 
of breast cancer risk. Decreased hepatic stearoyl-coA desaturase expression or 
activity may be related to decreased risk of breast cancer (Chajès et al., 2011). 
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Another striking observation is the significantly higher levels of lipids with longer 
fatty acid chains, with total carbon number of 40. Long chain fatty acids are 
synthesised by FAS, using acetyl-coA as a primer, malonyl-coA as a two-carbon 
donor and NADPH as a reducing equivalent (Asturias et al., 2005; Chirala and 
Wakil, 2004). ACC is the rate limiting enzyme for the synthesis of long chain 
fatty acids by catalysing the ATP-dependent carboxylation of acetyl-coA to 
malonyl-coA (Tong, 2005). It has been shown to be overexpressed both at mRNA 
and protein levels in advanced breast carcinomas and preneoplastic lesions 
associated with heightened risk for infiltrating breast cancer development 
(Milgraum et al., 1997). Knockdown of ACC impairs tumor cell proliferation and 
cause a decrease in cell viability (Brusselmans et al., 2005; Chajès et al., 2006).  
Carcinogenesis and development of the malignant phenotype usually occur in an 
avascular or hypoxic condition. This results in cancer cells adapting by switching 
into anaerobic metabolism, which allows the maintenance of metabolic activities 
without oxygen. FAS pathway is activated to provide the necessary oxidising 
power and consume reducing equivalents (ie NADPH) and tumor cells can 
synthesise longer fatty acids as they supply greater oxidising power (Menendez 
and Lupu, 2007). 
However, these differences in carbon chain length and degree of unsaturation in 
phospholipids and sphingolipids could not be linked to the cell cycle observations 
in Chapter 3. Although cell cycle dysregulation is a characteristic of cancer, it is 
certainly not the only one. The hallmarks of cancer consist of seven biological 
capabilities, including (i) sustaining proliferative signalling, (ii) evading growth 
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suppressors, (iii) resisting apoptosis, (iv) enabling replicative immortality, (v) 
inducing angiogenesis, (vi) activating invasion and (vii) metastasis (Hanahan and 
Weinberg, 2011). It is this combination of altered properties that make cancer 
proliferation so successful. Our cell cycle study in Chapter 3 addresses mainly 
one of the hallmarks- sustained proliferation. Hence, the changes in carbon chain 
length and degree of fatty acid unsaturation may be attributed to other hallmarks 
of cancer, instead of being cell cycle related. 
Elevated levels of cholesterol esters in tumor tissues were observed in this present 
study. Differences in the production of cholesterol esters and ACAT activity have 
been reported to differ between normal and cancerous tissues. In fact, higher 
proliferation rates in tumor cells have been correlated with their higher capacity to 
esterify cholesterol and accumulate cholesterol esters (Dessi et al., 1997; Gebhard 
et al., 1987; Tosi et al., 2003). Transcriptomics data also revealed a higher level of 
ACAT1 expression in human breast cancer cell lines and human breast tumors 
that were characterised as basal, triple negative (lacking estrogen receptor (ER), 
progesterone receptor, and ERBB2), or ER negative. High ACAT1 activity was 
associated with a higher LDL receptor level. Inhibition of both would lead to 
decrease in cell migration (Antalis et al., 2011), indicating that cholesterol esters 
accumulation is associated with aggressive cancer behavior. This agrees with 
another study where cholesterol esters were detected in ductal mammary 
carcinoma of Grade 3 while absent in the matched control tissues (Beckonert et al., 
2003). In fact, as shown in Chapter 3, dividing cells, or cells in G2/M phase of the 
cell cycle, also exhibited the same elevation in cholesterol esters as compared to 
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non-dividing cells. This further emphasises the importance of cholesterol esters in 




 6. CONCLUSION 
 
This thesis provides the first global lipid profile of the mammalian cell cycle. Two 
human cell lines, HeLa and MCF7, were used to study the lipid changes in the 
cell cycle. Two different synchronisation methods were also employed to analyse 
the cell cycle from G1/S to G2/M and from G2/M to G1, thus giving a more 
comprehensive picture of the lipid changes. No striking differences in 
phospholipids and sphingolipids in different stages of the cell cycle were found, 
contrary to the common belief that the cell lipidome would change dramatically 
during the cell cycle as there are dynamic membrane changes and movements in 
the process. This implies that the lipids are tightly regulated and under strict 
homeostasis. 
While there was no variation in other lipid classes during the different stages of 
the cell cycle, cholesterol esters were observed to significantly change in both cell 
lines and synchronisation methods. Levels of cholesterol esters were consistently 
higher in G2/M phase than in G1. This highlights a more significant role of 
cholesterol esters in cell division as compared to other lipids. While there are 
several reports on the relationship between cholesterol esters and cell growth, no 
major work has been done to knock down the main cholesterol ester synthesising 
gene (ACAT1) and observe synchronised cell cycle progression. Hence, we 
targeted cholesterol esters synthesis more specifically using ACAT1 siRNA, and 
analysed the cell cycle progression. It was observed that the ACAT1 KD cells 
took a longer time to exit from G2/M phase as compared to the negative control 
cells. Evidence and literature point to the possibility that ACAT1 synthesis of 
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cholesterol esters and storage into lipid droplets are essential for proper DNA 
replication in S phase, which will consequently affect G2/M progression. This 
was not observed previously. It was widely reported that cells treated with drugs 
that inhibit ACAT1 caused an accumulation of cells in G1 phase. Our work 
suggests that the G1 arrest observed by other groups may be due to the increased 
duration of the G2/M phase. 
One of the common diseases related to dysfunctional cell cycle is cancer. We thus 
decided to conduct a pilot study using breast cancer as a model. When we 
analysed breast tumor-control matched samples, we observed again a significantly 
higher levels of cholesterol esters in tumor tissues. This supports the observation 
that cholesterol esters are higher in actively dividing cells such as those in cancer 




 7. FUTURE WORK 
 
The reported results about the lipid profile of the cell cycle were carried out at the 
cellular scale. This may have masked important lipid changes during the cell 
cycle. Future work could be aimed at obtaining lipidomics data at organellar level, 
ie. focusing on the lipidome of various parts of the cells (lipid droplets, nucleus, 
mitochondria, and plasma membrane) at different stages of the cell cycle. As 
these organelles have to undergo membrane fission and fusion during replication, 
we could localise organelle-specific lipid changes. This may provide a more 
detailed and informative view. However, this approach could only be informative 
if the organellar fractions are homogenous and ensuring this would involve 
challenging experimental steps. 
Another method of profiling lipids with spatiotemporal information during the 
cell cycle would be to use a remarkable emerging technology, MS-Imaging. This 
technology enables scientists to determine distribution of biological molecules 
present in tissue sections by direct ionisation and detection. This eliminates the 
need for metabolite extraction, which causes the loss of spatial information 
(Miura et al., 2012). However, as the technology is still very young, there are 
some limitations like sensitivity, spatial and temporal resolution, as well as 
molecular coverage (Miura et al., 2012).  
In this study, cholesterol esters are flagged as the main lipids that show significant 
differences in G1/S and G2/M. The opposite trends observed in aphidicolin and 
nocodazole synchronisation support their importance. While we have analysed the 
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cell cycle kinetics in cholesterol ester depleted cells, more work can also be done 
to understand the mechanisms linking ACAT1 and cell growth more deeply. For 
instance, ACAT1 knockout animals could be used to observe tumor growth, or 
mice could be fed with ACAT1 inhibitor drugs and monitored for any tumor 
suppression. Here, we could not eliminate the possibility that the cell cycle arrest 
in ACAT1 KD cells is due to the parallel increase in cholesterol level. Hence, a 
combination of ACAT1 inhibitors and statins may probably be used to provide 
more controlled cholesterol and its esterified derivatives levels. Apart from 
analysing ACAT1, we could also investigate the role of its antagonist, cholesterol 
ester hydrolase, in the cell cycle. This may allow us to further understand the 
regulation of cholesterol esters in cell division.  
Another way to elucidate the role and fate of cholesterol esters in the cell cycle is 
to culture the cells in media containing cholesterol esters conjugated with 
fluorescent probes on the cholesterol position of the molecule. We would then be 
able to monitor cholesterol esters trafficking, from endocytosis to degradation, 
and then re-synthesis by ACAT1. We could then track the spatial and temporal 
aspects of cholesterol esters in the cell cycle, such as the stage at which 
cholesterol esters are broken down and the part of the cell where the product of 
cholesterol esters degradation is being channeled to.  
As shown in the present study, the increase in cholesterol esters in dividing cells 
has been reaffirmed in breast cancer tissues that were analysed and compared to 
their matched controls. Unfortunately, due to the small number of breast cancer 
tissues and their matched samples at this point, we were unable to differentiate 
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between the lipid profiles of different stages of the disease. With more samples, 
we believe that we would be able to observe a more defined trend in lipids across 





 8. BIBLIOGRPAHY 
 
Antalis, C., Uchida, A., Buhman, K., and Siddiqui, R. (2011). Migration of MDA-
MB-231 breast cancer cells depends on the availability of exogenous lipids and 
cholesterol esterification. Clin Exp Metastasis 28, 733-741. 
Asturias, F.J., Chadick, J.Z., Cheung, I.K., Stark, H., Witkowski, A., Joshi, A.K., 
and Smith, S. (2005). Structure and molecular organization of mammalian fatty 
acid synthase. Nat Struct Mol Biol 12, 225-232. 
Banfalvi, G. (2011). Synchronization of Mammalian Cells and Nuclei by 
Centrifugal Elutriation. In Cell Cycle Synchronization, G. Banfalvi, ed. (Humana 
Press), pp. 25-45. 
Bar-Joseph, Z., Siegfried, Z., Brandeis, M., Brors, B., Lu, Y., Eils, R., Dynlacht, 
B.D., and Simon, I. (2008). Genome-wide transcriptional analysis of the human 
cell cycle identifies genes differentially regulated in normal and cancer cells. 
PNAS 105, 995-960. 
Batetta, B., Mulas, M.F., Sanna, F., Putzolu, M., Bonatesta, R.R., Gasperi-
Campani, A., Roncuzzi, L., Baiocchi, D., and Dessì, S. (2003). Role of cholesterol 
ester pathway in the control of cell cycle in human aortic smooth muscle cells. 
The FASEB Journal. 
Batetta, B., Pani, A., Putzolu, M., Sanna, F., Bonatesta, R., Piras, S., Spano, O., 
Mulas, M.F., and Dessí, S. (1999). Correlation between cholesterol esterification, 
MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell 
lines. Cell Proliferation 32, 49-61. 
Beckonert, O., Monnerjahn, J., Bonk, U., and Leibfritz, D. (2003). Visualizing 
metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-
organizing maps. NMR in Biomedicine 16, 1-11. 
Bemlih, S., Poirier, M.-D., and Andaloussi, A.E. (2010). Acyl-coenzyme A: 
Cholesterol acyltransferase inhibitor Avasimibe affect survival and proliferation 
of glioma tumor cell lines. Cancer Biology & Therapy 9, 1025-1032. 
Bligh, E.G., and Dyer, W.J. (1959). A rapid method of total lipid extraction and 
purification. Can J Biochem Physiol 37, 911-917. 
Bollen, M., Gerlich, D.W., and Lesage, B. (2009). Mitotic phosphatases: from 
entry guards to exit guides. Trends in cell biology 19, 531-541. 




Braun-Dullaeus, R.C., Mann, M.J., and Dzau, V.J. (1998). Cell Cycle 
Progression : New Therapeutic Target for Vascular Proliferative Disease. 
Circulation 98, 82-89. 
Brown, A.H. (2012). Lipidomics: when apocrypha becomes canonical. Current 
Opinion in Chemical Biology 16, 221-226. 
Brügger, B., Erben, G., Sandhoff, R., Wieland, F.T., and Lehmann, W.D. (1997). 
Quantitative analysis of biological membrane lipids at the low picomole level by 
nano-electrospray ionization tandem mass spectrometry. Proceedings of the 
National Academy of Sciences 94, 2339-2344. 
Brusselmans, K., De Schrijver, E., Verhoeven, G., and Swinnen, J.V. (2005). 
RNA Interference–Mediated Silencing of the Acetyl-CoA-Carboxylase-α Gene 
Induces Growth Inhibition and Apoptosis of Prostate Cancer Cells. Cancer 
Research 65, 6719-6725. 
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J.P., Sedivy, 
J.M., Kinzler, K.W., and Vogelstein, B. (1998). Requirement for p53 and p21 to 
Sustain G2 Arrest After DNA Damage. Science 282, 1497-1501. 
Cai, L., and Tu, B.P. (2012). Driving the cell cycle through metabolism. Annual 
Review of Cell and Developmental Biology 28, 59-87. 
Cases, S., Novak, S., Zheng, Y.-W., Myers, H.M., Lear, S.R., Sande, E., Welch, 
C.B., Lusis, A.J., Spencer, T.A., Krause, B.R., et al. (1998). ACAT-2, A Second 
Mammalian Acyl-CoA:Cholesterol Acyltransferase: ITS CLONING, 
EXPRESSION, AND CHARACTERIZATION. Journal of Biological Chemistry 
273, 26755-26764. 
Castedo, M., Perfettini, J.-L., Roumier, T., Andreau, K., Medema, R., and 
Kroemer, G. (2004). Cell death by mitotic catastrophe: a molecular definition. 
Oncogene 23, 2825-2837. 
Cecchetti, S., Spadaro, F., Lugini, L., Podo, F., and Ramoni, C. (2007). 
Functional role of phosphatidylcholine-specific phospholipase C in regulating 
CD16 membrane expression in natural killer cells. European Journal of 
Immunology 37, 2912-2922. 
Cermelli, S., Guo, Y., Gross, S.P., and Welte, M.A. (2006). The lipid-droplet 
proteome reveals that droplets are a protein-storage depot. Current Biology 16, 
1783-1795. 
Chajès, V., Cambot, M., Moreau, K., Lenoir, G.M., and Joulin, V. (2006). Acetyl-




Chajès, V., Joulin, V., and Clavel-Chapelon, F. (2011). The fatty acid desaturation 
index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase 
expression, is a predictive factor of breast cancer risk. Current Opinion in 
Lipidology 22, 6-10 10.1097/MOL.1090b1013e3283404552. 
Chajès, V., Lanson, M., Fetissof, F., Lhuillery, C., and Bougnoux, P. (1995). 
Membrane fatty acids of breast carcinoma: Contribution of host fatty acids and 
tumor properties. International Journal of Cancer 63, 169-175. 
Chang, C.C., Huh, H.Y., Cadigan, K.M., and Chang, T.Y. (1993). Molecular 
cloning and functional expression of human acyl-coenzyme A:cholesterol 
acyltransferase cDNA in mutant Chinese hamster ovary cells. Journal of 
Biological Chemistry 268, 20747-20755. 
Chang, C.C.Y., Sakashita, N., Ornvold, K., Lee, O., Chang, E.T., Dong, R., Lin, 
S., Lee, C.-Y.G., Strom, S.C., Kashyap, R., et al. (2000). Immunological 
Quantitation and Localization of ACAT-1 and ACAT-2 in Human Liver and 
Small Intestine. Journal of Biological Chemistry 275, 28083-28092. 
Chang, T.Y., Chang, C.C.Y., and Cheng, D. (1997). Acyl-coenzyme A: 
cholesterol acyltransferase. Annual Review of Biochemistry 66, 613-638. 
Chen, H.W., Heiniger, H.J., and Kandutsch, A.A. (1975). Relationship between 
sterol synthesis and DNA synthesis in phytohemagglutinin-stimulated mouse 
lymphocytes. Proceedings of the National Academy of Sciences 72, 1950-1954. 
Chen, Z., Yu, Y., FU, D., Li, Z., Niu, X., Liao, M., and Lu, S. (2010). Functional 
roles of PC-PLC and Cdc20 in the cell cycle, proliferation and apoptosis. Cell 
Biochem Funct 28, 249-257. 
Cheng, S., and Levy, D. (1979). The effects of cell proliferation on the lipid 
composition and fluidity of hepatocyte plasma membranes. Archives of 
Biochemistry and Biophysics 196, 424-429. 
Chirala, S., and Wakil, S. (2004). Structure and function of animal fatty acid 
synthase. Lipids 39, 1045-1053. 
Cho, R.J., Campbell, M.J., Winzeler, E.A., Steinmetz, L., Conway, A., Wodicka, 
L., Wolfsberg, T.G., Garbielian, A.E., Landsman, D., Lockhart, D.J., et al. (1998). 
A genome-wide transcriptional analysis of the mitotic cell cycle. Molecular Cell 2, 
65-73. 
Cho, R.J., Huang, M., Campbell, M.J., Dong, H., Steinmetz, L., Sapinoso, L., 
Hampton, G., Elledge, S.J., Davis, R.W., and Lockhart, D.J. (2001). 
Transcriptional regulation and function during the human cell cycle. Nature 
Genetics 27, 48-54. 
 133 
 
Cohen, A.W., Razani, B., Schubert, W., Williams, T.M., Wang, X.B., Iyengar, P., 
Brasaemle, D.L., Scherer, P.E., and Lisanti, M.P. (2004). Role of Caveolin-1 in 
the Modulation of Lipolysis and Lipid Droplet Formation. Diabetes 53, 1261-
1270. 
Cornell, R.B., and Horwitz, A.F. (1980). Apparent Coordination of the 
Biosynthesis of lipids in cultured cells: Its relationship to the regulation of the 
membrane Sterol: Phospholipid ratio and cell cycling. The Journal of Cell 
Biology 86, 810-819. 
Cuadrado, A., Carnero, A., Dolfi, F., Jiménez, B., and Lacal, J. (1993). 
Phosphorylcholine: a novel second messenger essential for mitogenic activity of 
growth factors. Oncogene 8, 2959-2968. 
Cui, Z., and Thomas, M.J. (2009). Phospholipid profiling by tandem mass 
spectrometry. Journal of Chromatography B 877, 2709-2715. 
Cuperlovic-Culf, M., Barnett, D.A., Culf, A.S., and Chute, I. (2010). Cell culture 
metabolomics: applications and future directions. Drug Discovery Today 15, 610-
621. 
Daum, G., and Vance, J.E. (1997). Import of lipids into mitochondria. Progress in 
Lipid Research 36, 103-130. 
Davis, P.K., Ho, A., and Dowdy, S.F. (2001). Biological Methods for Cell-Cycle 
synchronisation of mammalian cells. BioTechniques 30, 1322-1331. 
de Laat, S.W., van der Saag, P.T., and Shinitzky, M. (1977). Microviscosity 
modulation during the cell cycle of neuroblastoma cells. Proceedings of the 
National Academy of Sciences 74, 4458-4461. 
DeBerardinis, R.J., Sayed, N., Ditsworth, D., and Thompson, C.B. (2008). Brick 
by brick: metabolism and tumor cell growth. Current Opinion in Genetics &amp; 
Development 18, 54-61. 
den Elzen, N., and Pines, J. (2001). Cyclin a Is Destroyed in Prometaphase and 
Can Delay Chromosome Alignment and Anaphase. The Journal of Cell Biology 
153, 121-136. 
Dennis, E.A. (2009). Lipidomics joins the omics evolution. PNAS 106, 2089-
2090. 
Dessi, S., Batetta, B., Pani, A., Spano, O., Sanna, F., Putzolu, M., Bonatesta, R., 
Piras, S., and Pani, P. (1997). Role of cholesterol synthesis and esterification in 
the growth of CEM and MOLT4 lymphoblastic cells. Biochem J 321, 603-608. 
Diaz-laviada, I., Larrodera, P., Diaz-Meco, M., Cornet, M., Guddal, P., Johansen, 
T., and Moscat, J. (1990). Evidence for a role of phosphatidylcholine-hydrolysing 
 134 
 
phospholipase C in the regulation of protein kinase C by ras and src oncogenes. 
EMBO 9, 3907-3912. 
Dowhan, W., Bogdanov, M., and Mileykovskaya, E. (2008). Functional roles of 
lipids in membranes. In Biochemistry of Lipids, Lipoproteins and Membranes, 
D.E. Vance, and J.E. Vance, eds. (Elsevier), pp. 1-38. 
Eliyahu, G., Kreizman, T., and Degani, H. (2007). Phosphocholine as a biomarker 
of breast cancer: Molecular and biochemical studies. International Journal of 
Cancer 120, 1721-1730. 
Emoto, K., Inadome, H., Kanaho, Y., Narumiya, S., and Umeda, M. (2005). Local 
change in phospholipid composition at the cleavage furrow is essential for 
completion of cytokinesis. The Journal of Biological Chemistry 280, 37901-
37907. 
Emoto, K., Kobayashi, T., Yamaji, A., Aizawa, H., Yahara, I., Inoue, K., and 
Umeda, M. (1996). Redistribution of phosphatidylethanolamine at the cleavage 
furrow of dividing cells duringâ€‰cytokinesis. Proceedings of the National 
Academy of Sciences 93, 12867-12872. 
Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., and Chen, J. (2001). 
Phosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling. Science 
294, 1942-1945. 
Fernández, M.A., Albor, C., Ingelmo-Torres, M., Nixon, S.J., Ferguson, C., 
Kurzchalia, T., Tebar, F., Enrich, C., Parton, R.G., and Pol, A. (2006). Caveolin-1 
Is Essential for Liver Regeneration. Science 313, 1628-1632. 
Fernándeza, C., Lobob, M.d.V.T., Gómez-Coronadoa, D., and Lasuncióna, M.A. 
(2004). Cholesterol is essential for mitosis progression and its deficiency induces 
polyploid cell formation. Experimental Cell Research 300, 109-120. 
Fox, M.H. (2003). Methods for synchronising mammalian cells. In Cell Cycle 
Checkpoint Control Protocols, H.B. Lieberman, ed. (Springer Protocols), pp. 11-
16. 
Fu, D., Ma, Y., Wu, W., Zhu, X., Jia, C., Zhao, Q., Zhang, C., and Wu, X.Z. 
(2009). Cell-cycle-dependent PC-PLC regulation by APC/CCdc20-mediated 
ubiquitin-proteasome pathway. Journal of Cellular Biochemistry 107, 686-696. 
Galbiati, F., Volonte', D., Liu, J., Capozza, F., Frank, P.G., Zhu, L., Pestell, R.G., 
and Lisanti, M.P. (2001). Caveolin-1 Expression Negatively Regulates Cell Cycle 
Progression by Inducing G0/G1 Arrest via a p53/p21WAF1/Cip1-dependent 
Mechanism. Molecular Biology of the Cell 12, 2229-2244. 
Gallaher, W., Weinstein, D., and Blough, H. (1973). Rapid turnover of principal 
phospholipids in BHK-21 cells. Biochem Biophys Res Commun 52, 1252-1256. 
 135 
 
Garcia, Z., Kumar, A., Marques, M., Cortes, I., and Carrera, A.C. (2006). 
Phosphoinositide 3-kinase controls early and late events in mammalian cell 
division. The EMBO Journal 25, 655-661. 
Gebhard, R.L., Clayman, R.V., Prigge, W.F., Figenshau, R., Staley, N.A., Reesey, 
C., and Bear, A. (1987). Abnormal cholesterol metabolism in renal clear cell 
carcinoma. Journal of Lipid Research 28, 1177-1184. 
Glunde, K., Jie, C., and Bhujwalla, Z. (2004). Molecular causes of the aberrant 
choline phospholipid metabolism in breast cancer. Cancer Research 64, 4270-
4276. 
Gross, G., Danzl, M., Fischer, W., and Brand, K. (1988). Alterations of cellular 
lipids in rat thymocytes during cell cycle progression. Biochimica et Biophysica 
Acta 962, 220-226. 
Ha, K.-S., and Exton, J.H. (1993). Activation of actin polymerisation by 
phosphatidic acid derived from phosphatidylcholine in IIC9 fibroblasts. J Cell 
Biol 123, 1789-1796. 
Hague, C.V., Postle, A.D., Attard, G.S., and Dymond, M.K. (2013). Cell cycle 
dependent changes in membrane stored curvature elastic energy: evidence from 
lipidomic studies. Faraday Discussions Advance Article. 
Han, X., and Gross, R.W. (2001). Quantitative Analysis and Molecular Species 
Fingerprinting of Triacylglyceride Molecular Species Directly from Lipid 
Extracts of Biological Samples by Electrospray Ionization Tandem Mass 
Spectrometry. Analytical Biochemistry 295, 88-100. 
Hanahan, D., and Weinberg, Robert A. (2011). Hallmarks of Cancer: The Next 
Generation. Cell 144, 646-674. 
Henry, S.M., and Hodge, L.D. (1983). Evidence for a unique profile of 
phosphatidylcholine synthesis in late mitotic cells. The Journal of Cell Biology 97, 
166-172. 
Hess, D., Chisholm, J.W., and Igal, R.A. (2010). Inhibition of StearoylCoA 
desaturase activity blocks cell cycle progression and induces programmed cell 
death in lung cancer cells. PLoS ONE 5, e11394. 
Hirsch, H.A., Iliopoulos, D., Joshi, A., Zhang, Y., Jaeger, S.A., Bulyk, M., 
Tsichlis, P.N., Shirley Liu, X., and Struhl, K. (2010). A Transcriptional Signature 
and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse 
Human Diseases. Cancer cell 17, 348-361. 
Hongo, S., Watanabe, T., Arita, S., Kanome, T., Kageyama, H., Shioda, S., and 
Miyazaki, A. (2009). Leptin modulates ACAT1 expression and cholesterol efflux 
 136 
 
from human macrophages. American Journal of Physiology - Endocrinology And 
Metabolism 297, E474-E482. 
Huang, F., Xiong, X., Wang, H., You, S., and Zeng, H. (2010). Leptin-induced 
vascular smooth muscle cell proliferation via regulating cell cycle, activating 
ERK1/2 and NF-kB. Acta Biochim Biophys Sin 42, 325-331. 
Huijbregts, R.P.H., Topalof, L., and Bankaitis, V.A. (2000). Lipid Metabolism 
and Regulation of Membrane Trafficking. Traffic 1, 195-202. 
Innocente, S.A., Abrahamson, J.L.A., Cogswell, J.P., and Lee, J.M. (1999). p53 
regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci U S A 96, 2147-
2152. 
Iorio, E., Mezzanzanica, D., Alberti, P., Spadaro, F., Ramoni, C., D'Ascenzo, S., 
Millimaggi, D., Pavan, A., Dolo, V., Canevari, S., et al. (2005). Alterations of 
Choline Phospholipid Metabolism in Ovarian Tumor Progression. Cancer 
Research 65, 9369-9376. 
Ito, M. (2000). Factors controlling cyclin B expression. Plant Molecular Biology 
43, 677-690. 
Ivanova, P.T., Milne, S.B., Myers, D.S., and Brown, H.A. (2009). Lipidomics: a 
mass spectrometry based systems level analysis of cellular lipids. Current Opinion 
in Chemical Biology 13, 526-531. 
Jackowski, S. (1994). Coordination of membrane phospholipids synthesis with the 
cell cycle. J Biol Chem 269, 3858-3867. 
Jackowski, S. (1996). Cell cycle regulation of membrane phospholipids 
metabolism. J Biol Chem 271, 20219-20222. 
Jordan, M.A., and Wilson, L. (2004). Microtubules as a target for anticancer 
drugs. Nat Rev Cancer 4, 253-265. 
Joshi, A.S., Zhou, J., Gohil, V.M., Chen, S., and Greenberg, M.L. (2009). Cellular 
functions of cardiolipin in yeast. Biochimica et Biophysica Acta - Molecular Cell 
Research 1793, 212-218. 
Kao, G.D., McKenna, W.G., Maity, A., Blank, K., and Muschel, R.J. (1997). 
Cylin B1 availability is a rate-limiting component of the radiaiton-induced G2 
delay in HeLa cells. Cancer Research 57, 753-758. 
Key, T.J., Verkasalo, P.K., and Banks, E. (2001). Epidemiology of breast cancer. 
Lancet Oncol 2, 133-140. 
Kiebish, M.A., Han, X., Cheng, H., Chuang, J.H., and Seyfried, T.N. (2008). 
Cardiolipin and electron transport chain abnormalities in mouse brain tumor 
 137 
 
mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J 
Lipid Res 49, 2545-2556. 
Kumar-Sinha, C., Ignatoski, K.W., Lippman, M.E., Ethier, S.P., and Chinnaiyan, 
A.M. (2003). Transcriptome Analysis of HER2 Reveals a Molecular Connection 
to Fatty Acid Synthesis. Cancer Research 63, 132-139. 
Kurat, C.F., Wolinski, H., Petschnigg, J., Kaluarachchi, S., Andrews, B., Natter, 
K., and Kohlwein, S.D. (2009). Cdk1/Cdc28-Dependent Activation of the Major 
Triacylglycerol Lipase Tgl4 in Yeast Links Lipolysis to Cell-Cycle Progression. 
Molecular Cell 33, 53-63. 
Lagarde, M., Sicard, B., Guichardant, M., Felisi, O., and Dechavanne, M. (1984). 
Fatty Acid Composition in Native and Cultured Human Endothelial Cells. In 
Vitro 20, 33-37. 
Lass, A., Zimmermann, R., Oberer, M., and Zechner, R. (2011). Lipolysis – A 
highly regulated multi-enzyme complex mediates the catabolism of cellular fat 
stores. Prog Lipid Res 50, 14-27. 
Laub, M., McAdams, H., Feldblyum, T., Fraser, S., and Shapiro, L. (2000). 
Global analysis of the genetic network contorlling a bacterial cell cycle. Science 
290, 2144-2148. 
Lee, O., Chang, C.C.Y., Lee, W., and Chang, T.-Y. (1998). Immunodepletion 
experiments suggest that acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-
1) protein plays a major catalytic role in adult human liver, adrenal gland, 
macrophages, and kidney, but not in intestines. Journal of Lipid Research 39, 
1722-1727. 
Li, F., Wu, N., Su, R.-B., Zheng, J.-Q., Xu, B., Lu, X.-Q., Cong, B., and Li, J. 
(2006). Involvement of phosphatidylcholine-selective phospholipase C in 
activation of mitogen-activated protein kinase pathways in imidazoline receptor 
antisera-selected protein. J Cell Biochem 98, 1615-1628. 
Lin, W., and Arthur, G. (2007). Phospholipids are synthesised in the G2/M phase 
of the cell cycle. The International Journal of Biochemistry & Cell Biology 39, 
597-605. 
Loewen, C. (2012). Lipids as conductors in the orchestra. F1000 Biology Reports 
4. 
Long, A.P., Manneschmidt, A.K., VerBrugge, B., Dortch, M.R., Minkin, S.C., 
Prater, K.E., Biggerstaff, J.P., Dunlap, J.R., and Dalhaimer, P. (2012). Lipid 
Droplet De Novo Formation and Fission Are Linked to the Cell Cycle in Fission 
Yeast. Traffic 13, 705-714. 
 138 
 
Lundgren, E., and Roos, G. (1976). cell surface changes in HeLa cells as an 
indication of cell cycle events. Cancer Research 36, 4044-4051. 
Ma, H., and Poon, R.C. (2011). Synchronization of HeLa Cells. In Cell Cycle 
Synchronization, G. Banfalvi, ed. (Humana Press), pp. 151-161. 
Madaan, K., Kaushik, D., and Verma, T. (2011). Hydroxyurea: a key player in 
cancer chemotherapy. Expert Review of Anticancer Therapy 12, 19-29. 
Malmberg, P., Nygren, H., Richter, K., Chen, Y., Dangardt, F., Friberg, P., and 
Magnusson, Y. (2007). Imaging of Lipids in Human Adipose Tissue by Cluster 
Ion TOF-SIMS. Microscopy Research and Technique 70, 828-835. 
Malumbres, M. (2011). Physiological relevance of cell cycle kinases. Physiol Rev 
91, 973-1007. 
Mansilla, F., Costa, K.-A.d., Wong, S., Kruhoffer, M., Lewin, T.M., Orntoft, R.F., 
colemn, R.A., and Birkenkamp-Demtroder, K. (2009). Lysophosphatidylcholine 
acyltransferase 1 (LPCAT1) overexoression in human colorectal cancer. J Mol 
Med 87, 85-97. 
Marazzi, J., Kleyer, J., Paredes, J.M.V., and Gertsch, J. (2011). Endocannabinoid 
content in fetal bovine sera- unexpected effects on mononuclear cells and 
osteoclastogenesis. Journal of Immunological Methods 373, 219-228. 
Martinez-Botas, J., Suarez, Y., Ferruelo, A.J., Gomez-Coronado, D., and 
Lasuncion, M.A. (1999). Cholesterol starvation decreases P34cdc2 kinase activity 
and arrests the cell cycle at G2. The FASEB Journal 13, 1359-1370. 
Meer, G.v. (2005). Cellular lipidomics. The EMBO Journal 24, 3159-3165. 
Menendez, J.A., and Lupu, R. (2007). Fatty acid synthase and the lipogenic 
phenotype in cancer pathogenesis. Nat Rev Cancer 7, 763-777. 
Mileykovskaya, E., Zhang, M., and Dowhan, W. (2005). Cardiolipin in energy 
transducing membranes. Biochemistry (Moscow) 70, 154-158. 
Milgraum, L.Z., Witters, L.A., Pasternack, G.R., and Kuhajda, F.P. (1997). 
Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast 
carcinoma. Clinical Cancer Research 3, 2115-2120. 
Milne, S., Ivanova, P., Forrester, J., and Brown, H.A. (2006). Lipidomics: An 
analysis of cellular lipids by ESI-MS. Methods 39, 92-103. 
Miura, D., Fujimura, Y., and Wariishi, H. (2012). In situ metabolomic mass 




Mollinedo, F., and Gajate, C. (2003). Microtubules, microtubule-interfering 
agents and apoptosis. Apoptosis 8, 413-450. 
Morgan-Lappe, S.E., Tucker, L.A., Huang, X., Zhang, Q., Sarthy, A.V., Zakula, 
D., Vernetti, L., Schurdak, M., Wang, J., and Fesik, S.W. (2007). Identification of 
Ras-Related Nuclear Protein, Targeting Protein for Xenopus Kinesin-like Protein 
2, and Stearoyl-CoA Desaturase 1 as Promising Cancer Targets from an RNAi-
Based Screen. Cancer Research 67, 4390-4398. 
Motallebipour, M., Enroth, S., Punga, T., Ameur, A., Koch, C., Dunham, I., 
Komorowski, J., Ericsson, J., and Wadelius, C. (2009). Novel genes in cell cycle 
control and lipid metabolism with dynamically regulated binding sites for sterol 
regulatory element-binding protein 1 and RNA polymerase II in HepG2 cells 
detected by chromatin immunoprecipitation with microarray detection. FEBS 
Journal 276, 1878-1890. 
Nagan, N., and Zoeller, R.A. (2001). Plasmalogens: biosynthesis and functions. 
Progress in Lipid Research 40, 199-229. 
Nagy, Z., Esiri, M., and Smith, A. (1998). The cell division cycle and the 
pathophysiology of Alzheimer's disease. Neuroscience 87, 731-739. 
Nakanishi, H., Iida, Y., Shimizu, T., and Taguchi, R. (2009). Analysis of oxidized 
phosphatidylcholines as markers for oxidative stress, using multiple reaction 
monitoring with theoretically expanded data sets with reversed-phase liquid 
chromatography/tandem mass spectrometry. Journal of Chromatography B 877, 
1366-1374. 
O'Brien, J., Wilson, I., Orton, T., and Pognan, F. (2000). Investigation of the 
Alamar Blue (resazurin) fluorscent dye for the assessment of mammalian cell 
cytotoxicity. Eur J Biochem 267, 5421-5426. 
Oakman, C., Tenori, L., Biganzoli, L., Santarpia, L., Cappadona, S., Luchinat, C., 
and Di Leo, A. (2011). Uncovering the metabolomic fingerprint of breast cancer. 
The International Journal of Biochemistry &amp; Cell Biology 43, 1010-1020. 
Oelkers, P., Behari, A., Cromley, D., Billheimer, J.T., and Sturley, S.L. (1998). 
Characterization of Two Human Genes Encoding Acyl Coenzyme A:Cholesterol 
Acyltransferase-related Enzymes. Journal of Biological Chemistry 273, 26765-
26771. 
Ogiso, H., Nakamura, K., Yatomi, Y., Shimizu, T., and Taguchi, R. (2010). 
Liquid chromatography/mass spectrometry analysis revealing preferential 
occurrence of non-arachidonate-containing phosphatidylinositol bisphosphate 
species in nuclei and changes in their levels during cell cycle. Rapid 
Communications in Mass Spectrometry 24, 436-442. 
 140 
 
Ong, E.S., Zou, L., Li, S., Cheah, P.Y., Eu, K.W., and Ong, C.N. (2010). 
Metabolic profiling in colorectal cancer reveals signature metabolic shifts during 
tumorigenesis. Molecular & Cellular Proteomics. 
Paillasse, M.R., de Medina, P., Amouroux, G., Mhamdi, L., Poirot, M., and 
Silvente-Poirot, S. (2009). Signaling through cholesterol esterification: a new 
pathway for the cholecystokinin 2 receptor involved in cell growth and invasion. 
Journal of Lipid Research 50, 2203-2211. 
Pani, A., Batetta, B., Putzolu, M., Sanna, F., Spano, O., Piras, S., Mulas, M.F., 
Bonatesta, R.R., Amat di S. Filippo, C., Vargiu, L., et al. (2000). MDR1, 
cholesterol esterification and cell growth: a comparative study in normal and 
multidrug-resistant KB cell lines. Cellular and Molecular Life Sciences 57, 1094-
1102. 
Pani, A., and Dessi, S. (2003). MDR-1, Cell Growth and Cholesterol 
Esterification. In Cell Growth and Cholesterol Esters, A. Pani, and S. Dessi, eds. 
(Eurekah.com and Kluwer Academic/Plenum Publishers), pp. 81-97. 
Park, M.-T., and Lee, S.-J. (2003). Cell cycle and cancer. Journal of Biochemistry 
and Molecular Biology 36, 60-65. 
Paton, C.M., and Ntambi, J.M. (2009). Biochemical and physiological function of 
stearoyl-CoA desaturase. American Journal of Physiology - Endocrinology And 
Metabolism 297, E28-E37. 
Pedrali-Noy, G., Spadari, S., Miller-Faurès, A., Miller, A.O., Kruppa, J., and 
Koch, G. (1980). Synchronization of HeLa cell cultures by inhibition of DNA 
polymerase alpha with aphidicolin. Nucleic Acids Research 8, 377-387. 
Podo, F., Canevari, S., Canese, R., Pisanu, M.e., Ricci, A., and Iorio, E. (2011). 
Tumor Phospholipid Metabolism. Proc Intl Soc Mag Reson Med 19. 
Preetha, A., Banerjee, R., and Huilgol, N. (2005). Surface activity, lipid profiles 
and their implications in cervical cancer. J Cancer Res Ther 1, 180-186. 
Pulfer, M., and Murphy, R.C. (2003). Electrospray mass spectrometry of 
phospholipids. Mass Spectrometry Reviews 22, 332-364. 
Puolitaival, S.M., Burnum, K.E., Cornett, D.S., and Caprioli, R.M. (2008). 
Solvent-Free Matrix Dry-Coating for MALDI Imaging of Phospholipids. Journal 
of the American Society for Mass Spectrometry 19, 882-886. 
Quesney-Huneeus, V., Wiley, M.H., and Siperstein, M.D. (1979). Essential role 




Rachel Katz-Brull, Dalia Seger, Dalia Rivenson-Segal, Edna Rushkin, and Degani, 
H. (2002). Metabolic Markers of Breast Cancer: Enhanced Choline Metabolism 
and Reduced Choline-Ether-Phospholipid Synthesis. Cancer Research 62, 1966-
1970. 
Ratnam, S., and Kent, C. (1995). Early Increase in Choline Kinase Activity upon 
Induction of the H-rasOncogene in Mouse Fibroblast Cell Lines. Archives of 
Biochemistry and Biophysics 323, 313-322. 
Richter, K., Nygren, H., Malmberg, P., and Hagenhoff, B. (2007). Localization of 
Fatty Acids with Selective Chain Length by Imaging Time-of-Flight Secondary 
Ion Mass Spectrometry. Microscopy Research and Technique 70, 640-647. 
Rieder, C.L., and Maiato, H. (2004). Stuck in Division or Passing through: What 
Happens When Cells Cannot Satisfy the Spindle Assembly Checkpoint. 
Developmental Cell 7, 637-651. 
Russell, L., and Forsdyke., D. (1991). A human putative lymphocyte G0/G1 
switch gene containing a CpG-rich island encodes a small basic protein with the 
potential to be phosphorylated. DNA Cell Biol 10, 581-591. 
Sakai, K., Okuyama, H., Yura, J., Takeyama, H., Shinagawa, N., Tsuruga, N., 
Kato, K., Miura, K., Kawase, K., Tsujimura, T., et al. (1992). Composition and 
turnover of phospholipids and neutral lipids in human breast cancer and reference 
tissues. Carcinogenesis 13, 579-584. 
Sakamaki, T., Casimiro, M.C., Ju, X., Quong, A.A., Katiyar, S., Liu, M., Jiao, X., 
Li, A., Zhang, X., Lu, Y., et al. (2006). Cyclin D1 Determines Mitochondrial 
Function In Vivo. Molecular and Cellular Biology 26, 5449-5469. 
Scaglia, N., Caviglia, J.M., and Igal, R.A. (2005). High stearoyl-CoA desaturase 
protein and activity levels in simian virus 40 transformed-human lung fibroblasts. 
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 
1687, 141-151. 
Scaglia, N., Chisholm, J.W., and Igal, R.A. (2009). Inhibition of StearoylCoA 
Desaturase-1 Inactivates Acetyl-CoA Carboxylase and Impairs Proliferation in 
Cancer Cells: Role of AMPK. PLoS ONE 4, e6812. 
Scaglia, N., and Igal, R.A. (2005). Stearoyl-CoA Desaturase Is Involved in the 
Control of Proliferation, Anchorage-independent Growth, and Survival in Human 
Transformed Cells. Journal of Biological Chemistry 280, 25339-25349. 
Scaglia, N., and Igal, R.A. (2008). Inhibition of Stearoyl-CoA Desaturase 1 
expression in human lung adenocarcinoma cells impairs tumorigenesis. 
International Journal of Oncology 33, 839-850. 
 142 
 
Schiffmann, S., Sandner, J., Birod, K., Wobst, I., Angioni, C., Ruckhäberle, E., 
Kaufmann, M., Ackermann, H., Lötsch, J., Schmidt, H., et al. (2009). Ceramide 
synthases and ceramide levels are increased in breast cancer tissue. 
Carcinogenesis 30, 745-752. 
Schori, C., and Sedivy, J.M. (2007). Analysis of Cell Cycle Phases and 
Progression in Cultured Mammalian Cells. Methods 41, 143-150. 
Schroepfer, G.J. (2000). Oxysterols: Modulators of Cholesterol Metabolism and 
Other Processes. Physiological Reviews 80, 361-554. 
Schütze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K., and Krönke, 
M. (1992). TNF activates NF-κB by phosphatidylcholine-specific phospholipase 
C-induced “Acidic” sphingomyelin breakdown. Cell 71, 765-776. 
Sekiya, M., Osuga, J.-i., Igarashi, M., Okazaki, H., and Ishibashi, S. (2011). The 
Role of Neutral Cholesterol Ester Hydrolysis in Macrophage Foam Cells. Journal 
of Atherosclerosis and Thrombosis 18, 359-364. 
Shankland, S.J., and Wolf, G. (2000). Cell cycle regulatory proteins in renal 
disease: role in hypertrophy, proliferation, and apoptosis. American Journal of 
Physiology - Renal Physiology 278, F515-F529. 
Shields, P.G., and Harris, C.C. (2000). Cancer Risk and Low-Penetrance 
Susceptibility Genes in Gene-Environment Interactions. Journal of Clinical 
Oncology 18, 2309-2315. 
Shtivelman, E., Sussman, J., and Stokoe, D. (2002). A Role for PI 3-Kinase and 
PKB Activity in the G2/M Phase of the Cell Cycle. Current biology : CB 12, 919-
924. 
Shui, G., Cheong, W.F., Jappar, I.A., Hoi, A., Xue, Y., Fernandis, A.Z., Tan, 
B.K.-H., and Wenk, M.R. (2011a). Derivatization-independent cholesterol 
analysis in crude lipid extracts by liquid chromatography/mass spectrometry: 
Applications to a rabbit model for atherosclerosis. Journal of Chromatography A 
1218, 4357-4365. 
Shui, G., Guan, X.L., Low, C.P., Chua, G.H., Goh, J.S.Y., Yang, H., and Wenk, 
M.R. (2010). Toward one step analysis of cellular lipidomes using liquid 
chromatography coupled with mass spectrometry: application to Saccharomyces 
cerevisiae and Schizosaccharomyces pombe lipidomics Molecular BioSystems, 
1008-1017. 
Shui, G., Stebbins, J.W., Lam, B.D., Cheong, W.F., Lam, S.M., Gregoire, F., 
Kusonoki, J., and Wenk, M.R. (2011b). Comparative Plasma Lipidome between 
Human and Cynomolgus Monkey: Are Plasma Polar Lipids Good Biomarkers for 
Diabetic Monkeys? PLoS ONE 6, e19731. 
 143 
 
Spandl, J., White, D.J., Peychl, J., and Thiele, C. (2009). Live Cell Multicolour 
Imaging of Lipid Droplets with a New Dye, LD540. Traffic 10, 1579-1584. 
Spector, A.A., and Yorek, M.A. (1985). Membrane lipid composition and cellular 
function. J Lipid Res 26, 1015-1035. 
Spellman, P., Sherlock, G., Zhang, M., Iyer, V., Anders, K., Eisen, M., Brown, P., 
Botstein, D., and Futcher, B. (1998). Comprehensive identification of cell cycle-
regulated genes of the yeast Saccaromyces cerevisiae by microarray hybridisation. 
Molecular Biology of the Cell 9, 3273-3297. 
Su, T.T., and Jaklevic, B. (2001). DNA damage leads to a Cyclin A–dependent 
delay in metaphase-anaphase transition in the Drosophila gastrula. Current 
Biology 11, 8-17. 
Sullards, M.C., and Merrill, A.H., Jr. (2001). Analysis of Sphingosine 1-
Phosphate, Ceramides, and Other Bioactive Sphingolipids by High-Performance 
Liquid Chromatography-Tandem Mass Spectrometry. Sci STKE 2001, pl1-. 
Sun, M., Paciga, J.E., Feldman, R.I., Yuan, Z.-q., Coppola, D., Lu, Y.Y., Shelley, 
S.A., Nicosia, S.V., and Cheng, J.Q. (2001). Phosphatidylinositol-3-OH Kinase 
(PI3K)/AKT2, Activated in Breast Cancer, Regulates and Is Induced by Estrogen 
Receptor α (ERα) via Interaction between ERα and PI3K. Cancer Research 61, 
5985-5991. 
Swinnen, J.V., Roskams, T., Joniau, S., Van Poppel, H., Oyen, R., Baert, L., 
Heyns, W., and Verhoeven, G. (2002). Overexpression of fatty acid synthase is an 
early and common event in the development of prostate cancer. International 
Journal of Cancer 98, 19-22. 
Tauchi-Sato, K., Ozeki, S., Houjou, T., Taguchi, R., and Fujimoto, T. (2002). The 
Surface of Lipid Droplets Is a Phospholipid Monolayer with a Unique Fatty Acid 
Composition. Journal of Biological Chemistry 277, 44507-44512. 
Taylor, W.R., and Stark, G.R. (2001). Regulation of the G2/M transition by p53. 
Oncogene 20, 1803-1815. 
Theron, T., and Bohm, L. (1998). Cyclin B1 expression in response to abrogation 
of the radiation-induced G2/M block in HeLa cells. Cell Prolif 31, 49-57. 
Ting, Y., Sherr, D., and Degani, H. (1996). Variations in energy and phospholipid 
metabolism in normal and cancer human mammary epithelial cells. Anticancer 
Research 16, 1381-1388. 
Tong, L. (2005). Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and 
attractive target for drug discovery. CMLS, Cell Mol Life Sci 62, 1784-1803. 
 144 
 
Tosi, M.R., Bottura, G., Lucchi, P., Reggiani, A., Trinchero, A., and Tugnoli, V. 
(2003). Cholesteryl esters in human malignant neoplasms. International journal of 
molecular medicine 11, 95-98. 
Vance, J., and Vance, D. (2004). Phospholipid biosynthesis in mammalian cells. 
Biochem Cell Biol 82, 113-128. 
Vander Heiden, M.G., Cantley, L.C., and Thompson, C.B. (2009). Understanding 
the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science 
324, 1029-1033. 
Vermeulen, K., Van Bockstaele, D.R., and Berneman, Z.N. (2003). The cell cycle: 
a review of regulation, deregulation and therapeutic targets in cancer. Cell 
Proliferation 36, 131-149. 
Visca, P., Sebastiani, V., Botti, C., BDiodoro, M.G., Lasagni, R.P., Romagnoli, F., 
Brenna, A., De Joannon, B.C., Donnorso, R.P., Lombardi, G., et al. (2004). Fatty 
Acid Synthase (FAS) is a Marker of Increased Risk of Recurrence in Lung 
Carcinoma. Anticancer Research 24, 4169-4174. 
Vitols, S., Norgren, S., Juliusson, G., Tatidis, L., and Luthman, H. (1994). 
Multilevel regulation of low-density lipoprotein receptor and 3-hydroxy- 3-
methylglutaryl coenzyme A reductase gene expression in normal and leukemic 
cells. Blood 84, 2689-2698. 
Vivanco, I., and Sawyers, C.L. (2002). The phosphatidylinositol 3-Kinase-AKT 
pathway in human cancer. Nat Rev Cancer 2, 489-501. 
Warburg, O., Posener, K., and Negelein, E. (1924). Ueber den Stoffwechsel der 
Tumoren. Biochemische Zeitschrift 152, 319-344. 
Welsh, C., Robinson, M., Warne, T., Pierce, J., Yeh, G., and Phang, J. (1994). 
Accumulation of fatty alcohol in MCF-7 breast cancer cells. Arch Biochem 
Biophys 15, 41-47. 
Welte, M.A., Li, Z., Manna, D., Thiel, K., and Beller, M. (2012). Lipid droplets 
control histone levels and promote mitotic fidelity in syncytial embryos. Paper 
presented at: Drosophila Genetics (Sheraton Chicago Hotel & Towers, Chicago 
IL.). 
Wenk, M.R. (2005). The emerging field of lipidomics. Nat Rev Drug Discov 4, 
594-610. 
Wenk, M.R. (2010). Lipidomics: New Tools and Applications. Cell 143, 888-895. 
Whitfield, M.L., Sherlock, G., Saldanha, A.J., Murray, J.I., Ball, C.A., Alexander, 
K.E., Matese, J.C., Perou, C.M., Hurt, M.M., Brown, p.O., et al. (2002). 
 145 
 
Identification of genes periodically expressed in the human cell cycle and their 
expression in tumours. Molecular Biology of the Cell 13, 1977-2000. 
Yahagi, N., Shimano, H., Hasegawa, K., Ohashi, K., Matsuzaka, T., Najima, Y., 
Sekiya, M., Tomita, S., Okazaki, H., Tamura, Y., et al. (2005). Co-ordinate 
activation of lipogenic enzymes in hepatocellular carcinoma. European journal of 
cancer (Oxford, England : 1990) 41, 1316-1322. 
Yang, X., Lu, X., Lombès, M., Rha, G.B., Chi, Y.-I., Guerin, T.M., Smart, E.J., 
and Liu, J. (2010). The G0/G1 Switch Gene 2 Regulates Adipose Lipolysis 
through Association with Adipose Triglyceride Lipase. Cell Metabolism 11, 194-
205. 
York, J.D., and Majerus, P.W. (1994). Nuclear phosphatidylinositols decrease 
during S phase of the cell cycle in HeLa cells. The Journal of Biological 
Chemistry 269, 7847-7850. 
Zhu, H., Yue, J., Pan, Z., Wu, H., Cheng, Y., Lu, H., Ren, X., Yao, M., Shen, Z., 
and Yang, J.-M. (2010). Involvement of Caveolin-1 in Repair of DNA Damage 
through Both Homologous Recombination and Non-Homologous End Joining. 
PLoS ONE 5, e12055. 
 
 
